<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><style scope="figure-callout">figure-callout:not([filenames=""]) a.figure-callout {
  cursor: zoom-in;
  text-decoration: underline;
  text-decoration-color: #ddd;
}</style><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><style scope="image-carousel">image-carousel {
  display: block;
}

.thumbnails.image-carousel {
  display: block;
        background-color: transparent;
        padding: 7px;
        white-space: nowrap;
        overflow: auto;
        font-size: 0;
}

.thumbnails.image-carousel img.image-carousel {
  margin-right: 7px;
        cursor: zoom-in;
}

.thumbnails.image-carousel img[selected].image-carousel {
  outline: solid 3px #4285f4;
}

.thumbnails.image-carousel img.image-carousel:last-of-type {
  margin-right: 0;
}</style><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: ""
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>RU2204838C2 - Vascular adhesion protein-1 of aminooxidase activity 
        - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/RU2204838C2/en">
    <meta name="description" content="
     FIELD: medicine. SUBSTANCE: the present innovation includes the method to manipulate binding process of endothelial cells with lymphocytes mediated with vascular adhesion protein-1 (VAP-1) including either inhibition or taking antilogarithms of aminooxidase enzymatic activity in mentioned endothelial cells. The present method mediates earlier interactions in the processes of binding lymphocytes and endothelial cells. EFFECT: higher efficiency. 2 cl, 6 dwg, 2 tbl 
   
   ">
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="Vascular adhesion protein-1 of aminooxidase activity 
       ">
    <meta name="DC.date" content="1998-05-22" scheme="dateSubmitted">
    <meta name="DC.description" content="
     FIELD: medicine. SUBSTANCE: the present innovation includes the method to manipulate binding process of endothelial cells with lymphocytes mediated with vascular adhesion protein-1 (VAP-1) including either inhibition or taking antilogarithms of aminooxidase enzymatic activity in mentioned endothelial cells. The present method mediates earlier interactions in the processes of binding lymphocytes and endothelial cells. EFFECT: higher efficiency. 2 cl, 6 dwg, 2 tbl 
   
   ">
    <meta name="citation_patent_application_number" content="RU:99128056/14A">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/d7/95/83/277f0f651b5594/RU2204838C2.pdf">
    <meta name="citation_patent_number" content="RU:2204838:C2">
    <meta name="DC.date" content="2003-05-20" scheme="issue">
    <meta name="DC.contributor" content="  (FI)" scheme="inventor">
    <meta name="DC.contributor" content=" " scheme="inventor">
    <meta name="DC.contributor" content="  (FI)" scheme="inventor">
    <meta name="DC.contributor" content=" " scheme="inventor">
    <meta name="DC.contributor" content="   (FI)" scheme="inventor">
    <meta name="DC.contributor" content="  " scheme="inventor">
    <meta name="DC.contributor" content="  (US)" scheme="inventor">
    <meta name="DC.contributor" content=" " scheme="inventor">
    <meta name="DC.contributor" content="  ." scheme="assignee">
    <meta name="citation_reference" content="SALMI M. et al., A 90-Kildalton endothelial cell Molecule mediating lymphocyte binding in humans, Science, 1992, v.257, Sept., .1407-1409." scheme="references">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            Vascular adhesion protein-1 of aminooxidase activity 
       </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><abstract mxw-id="PA145239354" lang="EN" load-source="patent-office" class="style-scope patent-text">
    <div class="abstract style-scope patent-text">FIELD: medicine. SUBSTANCE: the present innovation includes the method to manipulate binding process of endothelial cells with lymphocytes mediated with vascular adhesion protein-1 (VAP-1) including either inhibition or taking antilogarithms of aminooxidase enzymatic activity in mentioned endothelial cells. The present method mediates earlier interactions in the processes of binding lymphocytes and endothelial cells. EFFECT: higher efficiency. 2 cl, 6 dwg, 2 tbl</div>
  </abstract>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              
                <section id="thumbnails" class="style-scope patent-result">
                  <h3 class="style-scope patent-result">Images (<span class="style-scope patent-result">13</span>)</h3>
                  <image-carousel id="figures" class="style-scope patent-result">
    
    
      <div class="thumbnails style-scope image-carousel">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/a8/61/3d/5f5f232f4079b5/00000001.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/81/15/33/3a3349555a90f0/00000002.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/4d/11/2f/161f37d5d6092e/00000003.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/c7/2f/12/68baa3c3cee00d/00000004.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/fe/ec/54/5cdd902c48975e/00000005.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/d8/d1/e2/b32db6ec4a5ba0/00000006.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/c9/80/99/28125fc7137a78/00000007.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/01/1e/ff/b6c88d0e0f46e5/00000008.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/85/f7/82/9b03b4e88dcb0f/00000009.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/85/ef/30/8bff92bfb8817a/00000010.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/f2/4f/fd/2436492e3532ed/00000011.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/46/b2/3d/d8ffe59aaec13a/00000012.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/78/9b/3e/1f122a25aab738/00000013.png">
        <template is="dom-repeat" as="img" class="style-scope image-carousel"></template>
      </div>
    <template is="dom-if" class="style-scope image-carousel"></template>
  </image-carousel>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/00"><a id="link" href="#" class="style-scope state-modifier">C12N9/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/0004"><a id="link" href="#" class="style-scope state-modifier">C12N9/0004</a></state-modifier>
                  <span class="description style-scope classification-tree">Oxidoreductases (1.)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/0012"><a id="link" href="#" class="style-scope state-modifier">C12N9/0012</a></state-modifier>
                  <span class="description style-scope classification-tree">Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/0014"><a id="link" href="#" class="style-scope state-modifier">C12N9/0014</a></state-modifier>
                  <span class="description style-scope classification-tree">Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="C12N9/0022"><a id="link" href="#" class="style-scope state-modifier">C12N9/0022</a></state-modifier>
                  <span class="description style-scope classification-tree">Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/00"><a id="link" href="#" class="style-scope state-modifier">C12N9/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N9/0004"><a id="link" href="#" class="style-scope state-modifier">C12N9/0004</a></state-modifier>
                  <span class="description style-scope classification-tree">Oxidoreductases (1.)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="C12N9/0012"><a id="link" href="#" class="style-scope state-modifier">C12N9/0012</a></state-modifier>
                  <span class="description style-scope classification-tree">Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K"><a id="link" href="#" class="style-scope state-modifier">C07K</a></state-modifier>
                  <span class="description style-scope classification-tree">PEPTIDES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/00"><a id="link" href="#" class="style-scope state-modifier">C07K14/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/435"><a id="link" href="#" class="style-scope state-modifier">C07K14/435</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/705"><a id="link" href="#" class="style-scope state-modifier">C07K14/705</a></state-modifier>
                  <span class="description style-scope classification-tree">Receptors; Cell surface antigens; Cell surface determinants</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 2 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Health &amp; Medical Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Health &amp; Medical Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Life Sciences &amp; Earth Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Life Sciences &amp; Earth Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">RU2204838C2</h2>
                  <p class="tagline style-scope patent-result">Russia</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Patent for an invention or claims of a patent for an invention (second level)</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/d7/95/83/277f0f651b5594/RU2204838C2.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;vap&quot;,&quot;cells&quot;,&quot;sequence&quot;,&quot;protein&quot;,&quot;dna&quot;]" data-before="19970523"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/RU2204838C2"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  
                    <dt class="style-scope patent-result">Other languages</dt>
                    <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/RU2204838C2/ru"><a id="link" href="#" class="style-scope state-modifier">Russian</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="  (FI)"><a id="link" href="#" class="style-scope state-modifier">  (FI)</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor=" "><a id="link" href="#" class="style-scope state-modifier"> </a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="  (FI)"><a id="link" href="#" class="style-scope state-modifier">  (FI)</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor=" "><a id="link" href="#" class="style-scope state-modifier"> </a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="   (FI)"><a id="link" href="#" class="style-scope state-modifier">   (FI)</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="  "><a id="link" href="#" class="style-scope state-modifier">  </a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="  (US)"><a id="link" href="#" class="style-scope state-modifier">  (US)</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor=" "><a id="link" href="#" class="style-scope state-modifier"> </a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">1998</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CA2289903A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">CA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CA002289903A</div>
                <div class="style-scope application-timeline">Filing date: 1998-05-22</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO1998053049A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/FI1998/000429</div>
                <div class="style-scope application-timeline">Filing date: 1998-05-22</div>
                <div class="style-scope application-timeline">Legal status: IP Right Grant</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/HUP0002234A3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">HU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: HU0002234A</div>
                <div class="style-scope application-timeline">Filing date: 1998-05-22</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/KR100533911B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">KR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: KR10-1999-7010888A</div>
                <div class="style-scope application-timeline">Filing date: 1998-05-22</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/PL192459B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">PL</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PL337004A</div>
                <div class="style-scope application-timeline">Filing date: 1998-05-22</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CN1269829A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">CN</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CN98805369A</div>
                <div class="style-scope application-timeline">Filing date: 1998-05-22</div>
                <div class="style-scope application-timeline">Legal status: Pending</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/NZ501118A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">NZ</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: NZ501118A</div>
                <div class="style-scope application-timeline">Filing date: 1998-05-22</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU742098B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">AU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AU75314/98A</div>
                <div class="style-scope application-timeline">Filing date: 1998-05-22</div>
                <div class="style-scope application-timeline">Legal status: Expired</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP0979271A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP98922815A</div>
                <div class="style-scope application-timeline">Filing date: 1998-05-22</div>
                <div class="style-scope application-timeline">Legal status: Withdrawn</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP2001507238A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">JP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: JP55001798A</div>
                <div class="style-scope application-timeline">Filing date: 1998-05-22</div>
                <div class="style-scope application-timeline">Legal status: Ceased</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/RU2204838C2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline" this="">RU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: RU99128056/14A</div>
                <div class="style-scope application-timeline">Filing date: 1998-05-22</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">1999</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/NO995725D0/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">NO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: NO995725A</div>
                <div class="style-scope application-timeline">Filing date: 1999-11-22</div>
                <div class="style-scope application-timeline">Legal status: Application Discontinuation</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application RU99128056/14A events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="litigation style-scope application-timeline"></div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><a target="_blank" class="style-scope application-timeline" href="https://patents.darts-ip.com/?family=25338478&amp;utm_source=google_patent&amp;utm_medium=platform_link&amp;utm_campaign=public_patent_search&amp;patent=RU2204838(C2)"><span class="title-text style-scope application-timeline">First worldwide family litigation filed</span></a><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><iron-icon id="icon" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><overlay-tooltip positioning-target="#icon" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      <div class="description-item style-scope application-timeline">"Global patent litigation dataset by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.</div><template is="dom-repeat" class="style-scope application-timeline"></template>
    </div>
  </overlay-tooltip><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">1998-05-22</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="  ."><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by   .</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2001-12-20</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/RU99128056A/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of RU99128056A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="granted style-scope application-timeline">2003-05-20</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Application granted</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2003-05-20</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/RU2204838C2/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of RU2204838C2</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (2)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#nplCitations" class="style-scope patent-result">Non-patent citations (1)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (8)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=RU&amp;NR=2204838C2&amp;KC=C2&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/RU/2204838/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/RU2204838C2">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result">translated from Russian</div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><description mxw-id="PDES84014722" lang="EN" load-source="google" class="style-scope patent-text">
  <p num="1" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  <br class="style-scope patent-text">     ,       ,  VAP-1,       .          VAP-1.</span>Technical field <br class="style-scope patent-text"> The invention relates to a nucleic acid encoding a new human endothelial cell adhesion protein, designated VAP-1, which has an adhesive function and aminoxidase activity. The invention also relates to the use of a nucleic acid and a VAP-1 polypeptide.</span>
  </p>
  <p num="2" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  <br class="style-scope patent-text">              .           ,                .          ,     ,     .           ,        ,       ,      .   ,            ,          ,      .  ,          ,        ,      ,     .</span>BACKGROUND OF THE INVENTION <br class="style-scope patent-text"> The continuous circulation of lymphocytes between blood and tissue is crucial for the functioning of the immune system. This process allows lymphocytes to control all parts of the body in search of antigen, which allows them to develop and shape their response to the antigenic threat in specific conditions of the tissue microenvironment. After this, the lymphocytes can specifically return to the site with the microenvironment in which they found the antigen, which increases the selectivity of the immune response. Adhesive interactions between multiple receptors on circulating lymphocytes and their ligands expressed on the surface of endothelial cells in post-capillary venules are both a means of implementing the migration of leukocytes and a method of selectively controlling it. Despite the fact that significant progress has been made recently in the description of the cascade of processes necessary for the penetration of circulating leukocytes from the free bloodstream into the tissue, much in this process remains unclear. In particular, the currently known functions of adhesion molecules are not enough to explain all the recycling methods and binding specificity, the presence of which is shown both under normal conditions and under conditions of inflammation.</span>
  </p>
  <p num="3" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">             ,     ,        - (Butcher E.G. and Picker L., J. Science, 272:60-66 (1996); Springer . A., Cell, 76:301-314 (1994)).                   .          .               ,           Ig.                 ,          .                .          -      .</span>&nbsp;The current hypotheses come from a multi-stage model of adhesion of leukocytes with endothelium, which is based on a cascade of sequential, but overlapping molecular interactions between several receptor-ligand pairs (Butcher EG and Picker L., J. Science, 272: 60-66 (1996) ; Springer, T. A., Cell, 76: 301-314 (1994)). The initial temporary and limited interactions between the leukocyte in the bloodstream and the vascular wall are performed mainly by selectins and their glycoprotein ligands. At this stage, integrins and other molecules can take part. In the presence of corresponding signals, the next stage of strong adhesion can occur after the stages of rolling and testing, by binding the activated integrins to their ligands from the Ig superfamily. Locally elevated levels of immobilized cytokines and other chemoattractants may be involved in the initiation of such local activation, which is mediated by appropriate receptors and subsequent signal transduction within the cell. The final stage involves the process of migration of bound cells through the endothelial lining into the tissue through a very obscure mechanism. Tissue-specific circulation pathways are based on the regulation of the expression of certain receptor-ligand combinations of the adhesion molecule in the corresponding region of the body.</span>
  </p>
  <p num="4" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">      (MAT) 1B2,                   (HEV)     (Salmi M. and Jalkanen S., Science, 257:1407-1409 (1992);   NoNo. 5512442  5580780      No. 08/447799,        ). MAT 1B2            -1  (VAP-1).      VAP-1           (Salmi M. et al., J. Exp. Med., 178: 2255-2260 (1993)).       MAT 1B2      VAP-1    :      90 ,   170-180 .           170-180  (Salmi M. and Jalkanen S. , J. Exp. Med., 183:569-579 (1996)).  VAP-1             ,        ,     ,   ,        .    ,  VAP-1            - (McNab G. et al. , Gastroenterology, 110: 522-528 (1996)).  VAP-1       ,  VAP-1  , ,   ,  N-,  O-             - 2,36  2,6.   ,  VAP-1     HEV      ,      ,   ,     ,        (Salmi M. and Jalkanen S. , J. Exp. Med., 183:569-579 (1996)).          , ,    ,  ,   ,    (Arvilommi . -. et al., Eur. J. Immunol., 26: 825-833 (1996); Salmi M. et al., J. Exp. Med. , 178:2255-2260 (1993)). VAP-1    (PNAd)     (PLN),  MAT MECA-79,   VAP-1,   PNAd      PLN   . ,    PNAd, VAP-1     L-    L--  (Salmi M. and Jalkanen S., J. Exp. Med., 183:569-579 (1996)).  , VAP-1          ,       ,   ,          PLN  HEV.</span>&nbsp;A monoclonal antibody (MAT) 1B2 has previously been described that recognizes a new adhesion molecule for human endothelial cells and can block the binding of a lymphocyte to the superior endothelial tonsil venules (HEV) in an analysis of frozen sections (Salmi M. and Jalkanen S., Science, 257: 1407- 1409 (1992); U.S. Patent Nos. 5,512,442 and 5,580,780 and U.S. Patent Application No. 08/447799, which are incorporated herein by reference). MAT 1B2 is specific for this process and in this regard can determine vascular adhesion protein-1 (VAP-1). In inflammation, expression of surface VAP-1 is induced and the molecules are located on the surface of the endothelial cells in the vascular lumen (Salmi M. et al., J. Exp. Med., 178: 2255-2260 (1993)). By immunoprecipitation of tonsil tissue in the presence of MAT 1B2, two types of VAP-1 with different molecular weights can be detected: one of them has a mass of 90 kDa, and the second of 170-180 kDa. However, immunoblotting under non-reducing conditions leads to the predominance of molecules weighing 170-180 kDa (Salmi M. and Jalkanen S., J. Exp. Med., 183: 569-579 (1996)). Immunoreactive VAP-1s with slightly different molecular weights can also be found in other parts of the body, in particular in smooth muscle cells of the vascular network, as well as in other tissues containing smooth muscle cells, although their function in such cells remains unclear. McNab et al. Reported that VAP-1 is expressed on endothelial cells of the sinusoids of the liver and can mediate the process of T-lymphocyte binding (McNab G. et al., Gastroenterology, 110: 522-528 (1996)). Studies of VAP-1 from tonsils by cleavage with specific glycosidases showed that VAP-1 is a sialoglycoprotein containing, apparently, both N- and O-linked sugars in the presence of a large number of sialic acid residues with two types of bonds - 2.36 and 2.6. It has also been shown that VAP-1 mediates the binding of a lymphocyte to HEV in lymphatic tissues under shear conditions, and in connection with sialic acid, since the desialylated molecule, as shown by studies of frozen sections, can no longer participate in the binding of lymphocytes (Salmi M. and Jalkanen S., J. Exp. Med., 183: 569-579 (1996)). The molecule undergoes positive regulation in inflammatory conditions in diseases of the skin, intestines, tonsils and synovial membrane, although the mediators that cause this phenomenon have not yet been determined (Arvilommi A. -M. Et al., Eur. J. Immunol., 26: 825- 833 (1996); Salmi M. et al., J. Exp. Med., 178: 2255-2260 (1993)). VAP-1 differs from adressin (PNAd) from the peripheral lymph node (PLN) recognized by MAT MECA-79, although both VAP-1 and PNAd can mediate lymphocyte binding to PLN under shear conditions. However, unlike PNAd, VAP-1 can act independently of L-selectin and promote the binding of L-selectin-negative lymphocytes (Salmi M. and Jalkanen S., J. Exp. Med., 183: 569-579 (1996) ) Thus, VAP-1 is a molecule with an important adhesive function in the new cascade, which acts independently of the known selectins and, apparently, is able to mediate early interactions in the processes of lymphocyte binding to HEV type PLNs.</span>
  </p>
  <p num="5" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  <br class="style-scope patent-text">       ,   -1  (VAP-1),   ,  :<br class="style-scope patent-text"> ()    ,  ,   ,    1 (SEQ ID NO: 2);<br class="style-scope patent-text"> ()    ,  ,  VAP-1,    VAP-1,    1 (SEQ ID NO: 1);<br class="style-scope patent-text"> ()    ,   VAP-1,   ,    VAP-1,     No. DSM 11536;<br class="style-scope patent-text"> ()    ,   VAP-1   ,     No. DSM 11536;<br class="style-scope patent-text"> ()    ,   ,    VAP-1,   (), (), ()  ();<br class="style-scope patent-text"> ()    ,   ,         ()  (),      , <br class="style-scope patent-text"> ()    ,   ,     ()   VAP-1,   , ,   , 80%    VAP-1,    1 (SEQ ID NO:2).</span>SUMMARY OF THE INVENTION <br class="style-scope patent-text"> The invention relates to a purified nucleic acid molecule encoding vascular adhesion protein-1 (VAP-1) selected from the group consisting of: <br class="style-scope patent-text"> (a) a purified nucleic acid molecule encoding a polypeptide comprising the amino acid sequence shown in FIG. 1 (SEQ ID NO: 2); <br class="style-scope patent-text"> (b) a purified nucleic acid molecule comprising a sequence encoding VAP-1 from the nucleotide sequence of VAP-1 shown in FIG. 1 (SEQ ID NO: 1); <br class="style-scope patent-text"> (c) a purified nucleic acid molecule encoding a VAP-1 polypeptide comprising the amino acid sequence encoded by the VAP-1 cDNA clone stored in the depository under No. DSM 11536; <br class="style-scope patent-text"> (d) a purified nucleic acid molecule comprising the VAP-1 coding sequence of a nucleotide sequence stored in a depository under No. DSM 11536; <br class="style-scope patent-text"> (e) a purified nucleic acid molecule comprising a nucleotide sequence complementary to the nucleotide sequences of VAP-1 indicated in (a), (b), (c) or (d); <br class="style-scope patent-text"> (e) a purified nucleic acid molecule comprising a nucleotide sequence that is different from the coding sequence of a nucleic acid molecule (b) or (d) due to the degeneracy of the genetic code, and <br class="style-scope patent-text"> (g) a purified nucleic acid molecule comprising a nucleotide sequence that hybridizes with molecule (e) and encodes a VAP-1 having an amino acid sequence showing at least 80% identity with the VAP-1 sequence shown in Figure 1 (SEQ ID NO: 2).</span>
  </p>
  <p num="6" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">        ,   ,       VAP-1,   ,      .  ,     ,   ,  VAP-1.      VAP-1  -,   ,  VAP-1,  -.  ,  ,   -,     .         -1  (VAP-1),    -,  ,  VAP-1   ,  ,     VAP-1.</span>&nbsp;The invention further relates to a method for creating a recombinant vector, comprising introducing a molecule containing the sequence of the nucleic acid molecule for VAP-1 into a DNA sequence that can function as a vector. In addition, the invention relates to a recombinant vector comprising such a DNA encoding VAP-1. The invention relates to a method for delivering VAP-1 to a host cell, comprising introducing DNA encoding VAP-1 into a host cell. The invention further relates to a recombinant host cell containing the DNA thus introduced. The invention also relates to a method for producing a vascular adhesion protein-1 polypeptide (VAP-1), comprising culturing a recombinant host cell containing DNA encoding the VAP-1 of the present invention under conditions allowing expression of the encoded VAP-1 polypeptide.</span>
  </p>
  <p num="7" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">         -    ,  VAP-1, -.</span>&nbsp;The invention further relates to a method for providing aminoxidase activity of a host cell by transforming a host cell with a nucleic acid encoding VAP-1.</span>
  </p>
  <p num="8" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">         -1  (VAP-1), : ()   -  , : (i)   VAP-1  (ii)  ,     VAP-1,  ()  -  ,            VAP-1.      -,    VAP-1     .</span>&nbsp;The invention further relates to a method for altering the expression of vascular adhesion protein-1 (VAP-1), comprising: (a) introducing into the host cell a DNA construct containing: (i) the target sequence of VAP-1 and (ii) a regulatory sequence associated with the target VAP-1 sequence, and (b) the content of the host cell under conditions suitable for homologous recombination between the DNA construct and the endogenous VAP-1 sequence. The invention also relates to such a host cell in which the expression of VAP-1 has been altered by the above method.</span>
  </p>
  <p num="9" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">      -, : ()   VAP-1  ()  ,     VAP-1.</span>&nbsp;The invention also relates to a recombinant host cell comprising: (a) a target sequence of VAP-1; and (b) a regulatory sequence associated with a target sequence of VAP-1.</span>
  </p>
  <p num="10" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">      ,      VAP-1   .    , ,   .  VAP-1   ,   ,  95%  ,   ,  :<br class="style-scope patent-text"> (')  ,    VAP-1,    1 (SEQ ID NO: 2);<br class="style-scope patent-text"> (')  ,    VAP-1,    VAP-1,    1 (SEQ ID NO:1):<br class="style-scope patent-text"> (')  ,   ,    VAP-1,     No. DSM 11536;<br class="style-scope patent-text"> (')  ,    VAP-1,   ,     ,    (')-('),   VAP-1,    ,  ,   , 80%   ,    1 (SEQ ID NO:2), <br class="style-scope patent-text"> (')  ,         (')  (').</span>The invention relates to a method for oxidizing an amine, comprising reacting an amine with a VAP-1 polypeptide of the present invention. The amine may be, for example, benzylamine or methylamine. The VAP-1 polypeptide has an amino acid sequence at least 95% identical to the sequence selected from the group consisting of: <br class="style-scope patent-text"> (a ') a purified polypeptide comprising the amino acid sequence of VAP-1 shown in FIG. 1 (SEQ ID NO: 2); <br class="style-scope patent-text"> (b ') a purified polypeptide comprising the VAP-1 amino acid sequence encoded by the VAP-1 nucleotide sequence shown in Figure 1 (SEQ ID NO: 1): <br class="style-scope patent-text"> (c ') a purified polypeptide comprising the amino acid sequence encoded by the VAP-1 cDNA clone stored in the depository under No. DSM 11536; <br class="style-scope patent-text"> (g ') a purified polypeptide comprising a VAP-1 amino acid sequence encoded by a nucleotide sequence that hybridizes to a DNA complement encoding a type (a') - (B ') polypeptide and encodes a VAP-1 and has an amino acid sequence that demonstrates at least 80% identity with the sequence shown in figure 1 (SEQ ID NO: 2), and <br class="style-scope patent-text"> (d ') a purified polypeptide comprising the amino acid sequence of the epitope-containing portion of the polypeptide according to (a') or (b ').</span>
  </p>
  <p num="11" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">        ,       ,   .     , , , , , , , , , , 3,5--4-  MDL72145 (()-2-(3,4-)-3-).</span>&nbsp;The invention also relates to a method for inhibiting aminoxidase activity, comprising administering an effective amount of an inhibitor to a sample having aminoxidase activity. Said inhibitor may be, for example, semicarbazide, hydroxylamine, propargylamine, isoniazid, nialamide, hydralazine, procarbazine, monomethylhydrazine, 3,5-ethoxy-4-aminomethylpyridine or MDL72145 ((E) -2- (3,4-dimethoxyphenyl) - 3-fluoroallyl amine).</span>
  </p>
  <p num="12" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">            ,   -1  (VAP-1),            .</span>&nbsp;The invention also relates to a method of manipulating the process of binding of endothelial cells to lymphocytes, mediated by vascular adhesion protein-1 (VAP-1), comprising changing the enzymatic activity of aminoxidase in endothelial cells through inhibition or potentiation.</span>
  </p>
  <p num="13" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">   <br class="style-scope patent-text"> . 1.   VAP-1,    ,    ,     VAP-1. N-,   V8 ,         VAP-1,   .  ,    ,   ,   ,            -  .   N-    ,       -    .     5  27  .           (  TMD ),            N    ,    N-  O- .    50 .</span>Brief Description of the Drawings <br class="style-scope patent-text"> FIG. 1. The VAP-1 cDNA sequence isolated from the cDNA library isolated from the human lung, and the predicted VAP-1 protein sequence. The N-terminal, tryptic and V8 peptides that have been purified and sequenced from the immunopurified VAP-1 protein are enclosed in a rectangle. Amino acid residues, especially highlighted in the areas outlined in a rectangle, indicate that some amino acid residue cannot be assigned to this cycle during peptide sequencing. Potential N-glycosylation sites are indicated by circles with arrows, while asparagines and putative O-glycosylation sites are indicated by square arrows. The transmembrane domain between <figure-callout id="5" label="residues" filenames="00000004.png,00000009.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">residues</a></figure-callout> 5 and 27 is marked by blackout. The scale of the diagram at the bottom of the figures indicates the position of the transmembrane domain (shown by the filled TMD region), and the relative location of the putative glycosylation sites in the extracellular part of the molecule is labeled N or O to denote N- and O-linked sugar, respectively. A large arrow indicates 50 amino acids.</span>
  </p>
  <p num="14" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> . 2.        (FACS ) COS-7 ,   VAP-1,       VAP-1  . ,      VAP-1,    COS-7 ,     . VAP-1      VAP-1. FLAG VAP-1   VAP-1   FLAG,   .    ,     "",  ,   VAP-1     .  1:  ,   .  2:   (-)    (+)   .  3:    MAT .  4:    MAT 1B2  VAP-1.  5:    MAT M2  FLAG.  A-F       "",   ,     .      .        MAT 1B2  VAP-1 (         ,  4).   ""     (       ,  4).      MAT  FLAG  VAP-1 FLAG-  ( ,  5). ,    , VAP-1-        ( ,  4),   VAP-1 FLAG-       MAT  FLAG ( F,  5),    ,      MAT  FLAG       FLAG ,      ,      .</span>&nbsp;FIG. 2. Analysis by cell sorting by fluorescence intensity (FACS analysis) of COS-7 cells transfected relative to VAP-1, to determine the orientation of the membrane and the location of VAP-1 in the cell. A diagram showing the structure of two VAP-1 expression plasmids used to transfect COS-7 cells is shown at the top of the figure. VAP-1 is a native construct for the expression of VAP-1. FLAG VAP-1 is VAP-1 with the FLAG epitope introduced for labeling. Negative control on pseudotransfection, let's call it pseudo-control for brevity, is provided by a design in which VAP-1 has the opposite orientation of the expression vector. Column 1: Expression of the construct used for transfection. Column 2: Lack of permeabilization (-) or the presence of permeabilization (+) in transfected cells. Column 3: Negative control with MAT staining. Column 4: Staining using MAT 1B2 against VAP-1. Column 5: Staining using MAT M2 against FLAG. Rows A-F indicate expression construct or pseudo-control test used for transfection and staining results of transfected cells. Arrows indicate positively stained cell populations. On non-permeabilized cells, staining is noted when using MAT 1B2 against VAP-1 (rows B and C of the cell sorting pattern according to fluorescence intensity, column 4). The test for "pseudo-control" of transfected cells was negative (row A of the cell sorting pattern by fluorescence intensity, column 4). No staining was observed when using MAT against FLAG in VAP-1 FLAG-transfected cells (row C, column 5). However, in the case of permeabilized cells, VAP-1-transfected cells are still positive for staining (row E, column 4), while VAP-1 FLAG-transfected cells also stain positively using MAT against FLAG (row F, column 5 ), which indicates that the permeabilization of cells against MAT against FLAG allows these antibodies to access the FLAG epitope, and this indicates that this epitope lies inside the cell.</span>
  </p>
  <p num="15" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> . 3.      ,      ,  VAP-1.     ,   .      ; VAP-1     ; O1     1; O2 -    2;   -  .         .              GCG Pileup. ,    VAP-1,     GCG Box-shade.</span>&nbsp;FIG. 3. Alignment of representatives of the family of mammalian copper aminoxidases for which sequence data are available, including VAP-1. Labels on the left refer to a specific protein located to the right. BSAO is bovine serum aminoxidase; VAP-1 refers to human vascular adhesion protein; PDAO1 is human <figure-callout id="1" label="placental diamine oxidase" filenames="00000004.png,00000007.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">placental diamine oxidase</a></figure-callout> 1; PDAO2 - placental diamine oxidase of <figure-callout id="2" label="human" filenames="00000008.png,00000009.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">human</a></figure-callout> 2; DAO rat - rat diaminoxidase. The numbers correspond to the first amino acid in each row of grouped proteins. The sequences are taken from the latest available database and grouped using the GCG Pileup program. Residues characterized by identity with VAP-1 were isolated using the GCG Box-shade program.</span>
  </p>
  <p num="16" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> . 4.   VAP-1,   COS-7 .    VAP-1-   COS-7    (+)    (-)   -,        MAT 1B2  VAP-1 ( 1-4)        MAT 3G6 ( 5-8).</span>&nbsp;FIG. 4. Sialidase treatment of VAP-1 expressed in COS-7 cells. Cell lysates from VAP-1-transfected and pseudotransfected COS-7 cells are treated with sialidase (+) or not (-) before SDS-PAGE, followed by immunoblotting and treatment with a MAT 1B2 probe for VAP-1 (lanes 1-4) or a negative control test using MAT 3G6 (lanes 5-8).</span>
  </p>
  <p num="17" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> . 5. . -  VAP-1   <sup class="style-scope patent-text">+</sup> ,         ,         .    4,2     . . -  VAP-1    . -   Clon-tech Laboratories        .    <sup class="style-scope patent-text">32</sup>-   VAP-1,    ,       (   : 0,1  SSC, 0,1%   65<sup class="style-scope patent-text">o</sup>,    45 ).</span>FIG. 5. A. Northern blotting of VAP-1 mRNA with poly A <sup class="style-scope patent-text">+</sup> RNA isolated from smooth muscles of the human intestine and stroma of the tonsils, from which lymphocytes were partially removed by washing and compression. A 4.2 kilobyte hybridized mRNA is visible on both tracks. B. Northern blotting of VAP-1 mRNA from various human tissues. Northern blots were obtained from Clon-tech Laboratories and an equal amount of mRNA was added to each lane. All filters are loaded with <sup class="style-scope patent-text">32</sup> P-labeled VAP-1 cDNA probes containing the complete coding sequence and washed under strict control (washing conditions after hybridization: 0.1 x SSC, 0.1% SDS at 65 <sup class="style-scope patent-text"></sup> C, twice for 45 minutes).</span>
  </p>
  <p num="18" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> . 6. Ax ,   VAP-1,   . .  VAP-1    ,    VAP-1     "".                   Y. .   VAP-1-    VAP-1-.    PBL (      ,    )   VAP-1- (),    ().  ,   100. .   .    ,       .</span>&nbsp;FIG. 6. Ax cells transfected with VAP-1 cDNA mediate lymphocyte adhesion. A. Expression of VAP-1 on the surface of Ax cells stably transfected with VAP-1 cDNA or in a pseudo-control test. In the histograms, the staining intensity on a logarithmic scale is shown on the X axis and the relative number of cells is shown on the Y axis. B. Increase in the level of VAP-1-dependent binding of lymphocytes to VAP-1 transfectants. A significantly larger number of PBLs (small circular spheres on the upper part of the monolayer, examples of which are indicated by arrows) are associated with VAP-1 transfectants (left) than with pseudotransfectants (right). Phase-contrast micrographs, <figure-callout id="100" label="magnification x" filenames="00000004.png,00000013.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">magnification x</a></figure-callout> 100. C. Quantification of binding. The results of five independent experiments are presented as mean  SD.</span>
  </p>
  <p num="19" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">   <br class="style-scope patent-text">                            ,          .   ,   -1  (VAP-1),     - . ,   VAP-1   . ,           (McIntire W. and . Hartmann, in Principles and Applications of Quinoproteins, V. L. Davidson, ed. , Marcel Dekker, Inc., N. Y., Chap. 6 (1992)).</span>DETAILED DESCRIPTION OF THE INVENTION <br class="style-scope patent-text"> The interaction between the receptors on the surface of leukocytes and their ligands on the vascular endothelial cells is a crucial step in the mechanism for controlling the movement of lymphocytes between the blood and various lymphoid organs, and is also related to the transudation of leukocytes to the site of inflammation. A clone of a cDNA encoding vascular adhesion protein-1 (VAP-1), which mediates the adhesion reaction of a leukocyte-endothelial cell, is described. It turned out that the encoded VAP-1 has aminoxidase activity. In higher organisms, aminoxidase is believed to be involved in the metabolism of biogenic amines (McIntire W. and C. Hartmann, in Principles and Applications of Quinoproteins, VL Davidson, ed., Marcel Dekker, Inc., NY, Chap. 6 (1992)).</span>
  </p>
  <p num="20" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">        ,  ,    -1  (VAP-1),   ,    1 (SEQ ID NO:2),      ,   ,    1 (SEQ ID NO: 1). ,    ,            (International Depository Authority of DSMZ-Deutsche Sammlung Von Mikroorganismen Und Zeilkulturen GmbH)   Mascheroder Weg 1b, D-38124 Braunschweig, , 7  1997   No. DSM 11536.      pUC19.</span>&nbsp;The present invention relates to a purified nucleic acid molecule comprising a polynucleotide encoding a vascular adhesion protein-1 polypeptide (VAP-1) having the amino acid sequence shown in FIG. 1 (SEQ ID NO: 2), which was determined by sequencing a cDNA clone having a nucleotide the sequence shown in figure 1 (SEQ ID NO: 1). A clone containing the indicated nucleotide sequence was deposited in accordance with the terms of the Budapest Treaty with the International Depository Authority of DSMZ-Deutsche Sammlung Von Mikroorganismen Und Zeilkulturen GmbH at Mascheroder Weg 1b, D-38124 Braunschweig, Germany, May 7, 1997 under No. DSM 11536. The deposited clone is contained in plasmid pUC19.</span>
  </p>
  <p num="21" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">      (MAT)          VAP-1,  90  170-180  ,              ,           V8.  VAP-1  90    N-                     -   ,      .</span>&nbsp;Monoclonal antibody (MAT) column for immunoaffinity separation purified VAP-1 monomeric and dimeric forms of 90 and 170-180 kDa, respectively, which were isolated from detergent-treated smooth muscle lysates in sufficient quantities to determine the internal peptide sequence after cleavage with trypsin and protease V8. A 90 kDa portion of VAP-1 was subjected to N-terminal sequencing and used to construct partially degenerate oligonucleotide primers for experiments using RT-PCR reverse transcriptase polymerase chain reaction using mRNA obtained from the smooth muscles of the human gut.</span>
  </p>
  <p num="22" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">      700           pUC18     .                      ,    VAP-1,  ,   ,       VAP-1,    .      ,      ,    .         2501  ,    1 (SEQ ID N:1),         2292 ..,   - ,     pUC19.       VAP-1,         1 (SEQ ID N:1),    ,    763  ,    1 (SEQ ID NO:2),       80-82  ,    1 (SEQ ID N:1),     84,6 .</span>&nbsp;One cDNA fragment of approximately 700 nucleotide pairs in size is amplified using the indicated primers and cloned into pUC18 to determine its sequence. To detect longer cDNA clones by PCR, a set of four human cDNAs is analyzed in a cDNA library to determine those that contain VAP-1 cDNAs, and libraries showing the highest signal are screened using the resulting VAP-1 cDNA fragment PCR In this way, many overlapping cDNA clones are isolated from cDNA libraries isolated from a human lung and heart. From these clones, one cDNA of the size of 2501 nucleotide pairs was obtained, described in FIG. 1 (SEQ ID NO: 1), which contains a continuous open reading frame of 2292 bp starting from the ATG-methionine codon and further subcloned into pUC19 . The thus determined nucleotide sequence of the VAP-1 cDNA contained in this clone and shown in Figure 1 (SEQ ID NO: 1) contains an open reading frame encoding a protein of 763 amino acid residues shown in Figure 1 (SEQ ID NO: 2) , with the location of the initiating codon in the area 80-82 of the nucleotide sequence shown in figure 1 (SEQ ID NO: 1), having a molecular weight of about 84.6 kDa.</span>
  </p>
  <p num="23" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> VAP-1         ,     ( 1.4.3.6.).  VAP-1,    1 (SEQ ID N:2),   24%   u- Escherichia coli   41-81%       .          (81%).</span>&nbsp;VAP-1 of the present invention has a pronounced identity to the family of enzymes related to copper-containing aminoxidases (EC 1.4.3.6.). The VAP-1 protein shown in Figure 1 (SEQ ID NO: 2) is characterized by approximately 24% identity with Escherichia coli Cu monoamine oxidase and has 41-81% similarity with members of this family in mammals. The highest identity was shown with bovine serum aminoxidase (81%).</span>
  </p>
  <p num="24" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">    ,      " "     ( A, G,   ).    " "          ,    .            (, G,   U),     ()        (U).</span>&nbsp;Unless otherwise indicated, the term nucleotide sequence as described herein refers to a sequence of deoxyribonucleotides (abbreviated A, G, C, and T). Moreover, by the "nucleotide sequence" of a nucleic acid molecule or polynucleotide is meant a DNA or polynucleotide molecule consisting of a sequence of deoxyribonucleotides. In the case of an RNA or polynucleotide molecule, the corresponding sequence consists of ribonucleotides (A, G, C and U), where each thymidine deoxyribonucleotide (T) in a specific deoxyribonucleotide sequence is replaced by a uridine ribonucleotide (U).</span>
  </p>
  <p num="25" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">          ,     ,     ,       .      .         ,     ,   ,     ,  .</span>&nbsp;The nucleic acid molecules of the present invention may be RNA, such as mRNA or DNA, including cDNA and genomic DNA, obtained by cloning or during synthesis. DNA may be double-stranded or single-stranded. Single-stranded DNA or RNA can be a coding chain, also known as a sense strand, or a non-coding strand, also called an antisense strand, or complement.</span>
  </p>
  <p num="26" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">   () ""       -   ,        .      in vitro        .</span>&nbsp;By the term purified nucleic acid molecule (s) is meant a nucleic acid molecule  DNA or RNA  that is isolated from a native source or synthetically prepared. Purified RNA molecules include in vitro-derived RNA transcripts or DNA molecules of the present invention.</span>
  </p>
  <p num="27" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">            ,   VAP-1,   ,   ,   ,    7  1997 .  No. DSM 11536.        ,   ,    1 (SEQ ID NO:1),     VAP-1,      ,     ,  ,      .   ,    ,          in situ        VAP-1   , ,  --.</span>&nbsp;In another aspect, the present invention relates to purified nucleic acid molecules encoding a VAP-1 polypeptide having the amino acid sequence encoded by a cDNA clone contained in a plasmid deposited in the depository on May 7, 1997 under No. DSM 11536. The invention also relates to a purified nucleic acid molecule having the nucleotide sequence shown in Figure 1 (SEQ ID NO: 1), or the nucleotide sequence of the VAP-1 cDNA contained in the deposited clone described above, or to a nucleic acid molecule having a sequence complementary to one of the above sequences. Such isolated molecules, in particular DNA molecules, are used as probes for gene mapping during in situ hybridization with chromosomes and for detecting the expression of the VAP-1 gene in human tissues, for example, by Northern blot analysis.</span>
  </p>
  <p num="28" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">          ,    .      ,    VAP-1      VAP-1,    1 (SEQ ID NO:1),   ,   ,  15    ,   ,  20 ,   ,   ,  30     ,   ,  40   ,             . ,     50-1500        ,    ,     ,      ,    1 (SEQ ID NO:1).   VAP-1  ,    ,    1 (SEQ ID NO: 1),             . , ,         ,   ,     .</span>&nbsp;Further, the present invention relates to fragments of purified nucleic acid molecules described in the present description. By a fragment of a purified nucleic acid molecule having the VAP-1 nucleic acid sequence of the deposited cDNA or the VAP-1 nucleotide sequence shown in Figure 1 (SEQ ID NO: 1), we mean fragments of at least about 15 nucleotides in size and more preferably at least about 20 nucleotides, even more preferably at least about 30 nucleotides and even more preferably at least about 40 nucleotides in length, which are used as diagnostic probes and primers in accordance with description. Of course, larger fragments with a length of 50-1500 nucleotides can also be used in the framework of the present invention, if they are fragments that correspond mainly or completely to the nucleotide sequence of the deposited cDNA or the sequence shown in figure 1 (SEQ ID NO: 1). Since the VAP-1 gene was deposited and the nucleotide sequence shown in Figure 1 (SEQ ID NO: 1) is known, the creation of such DNA fragments is a routine for those skilled in the art. So, for example, to create fragments of different lengths, procedures such as restriction enzyme digestion, sonication disruption, or oligonucleotide synthesis can be used.</span>
  </p>
  <p num="29" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">           ,  ,                ,  ,     VAP-1,     No. DSM 11536.  "  "       42<sup class="style-scope patent-text">o</sup>  ,  50% , 5 x SSC (150  NaCl, 15   ), 50    ( 7,6), 5   , 10%    20 / ,    ,      0,1 x SSC    65<sup class="style-scope patent-text">o</sup>.</span>In another aspect, the invention relates to a purified nucleic acid molecule comprising a polynucleotide that hybridizes under strict hybridization control with a portion of the polynucleotide in the nucleic acid molecule of the present invention described above, for example, with a VAP-1 cDNA clone stored in a depository under No. DSM 11536. By stringent hybridization control is meant overnight incubation at 42 <sup class="style-scope patent-text"> C.</sup> in a solution comprising 50% formamide, 5 x SSC (150 mM NaCl, 15 mM trisodium citrate salt), 50 mM sodium phosphate (pH 7.6) , 5 x Denhardt's solution, 10% dextran sulfate and 20 g / ml denatured, destroyed salmon sperm DNA, followed by washing the filters in 0.1 x SSC at a temperature of about 65 <sup class="style-scope patent-text">o</sup> C.</span>
  </p>
  <p num="30" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  ,    ""    ( ,  ), ,   ,   15  ()   ,   ,   20 ,   ,   ,   30       30-70    .        . , ,        (,    ),     50-750        ,         ,     ,        VAP-1     ,    1 (SEQ ID NO: 1).               ,            (),     (,  Molecular Cloning, A Laboratory Manual, 2nd edition, Sambrook J., Fritsch E. F. and Maniatis ., eds.. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.(1989)),        .</span>&nbsp;A nucleotide that hybridizes to a part of a polynucleotide is understood to mean a polynucleotide (either DNA or RNA) that hybridizes for at least 15 nucleotides (nt) and more preferably at least about 20 nt, even more preferably at least about 30 nt and even more preferably about 30-70 nt with a standard polynucleotide. They can be used as diagnostic probes and primers. Of course, polynucleotides that hybridize to a greater extent with a standard polynucleotide (for example, a cloned deposited cDNA), for example, in a region of 50-750 nt long or even longer with a standard polynucleotide, can also be used as probes of the present invention, if they are polynucleotides corresponding to the main or full nucleotide sequence of VAP-1 deposited cDNA or the nucleotide sequence shown in figure 1 (SEQ ID NO: 1). Such parts are used for diagnostic purposes, either as probes in the traditional technique of DNA hybridization, or as primers for amplification of the target sequence in the polymerase chain reaction (PCR), as described in the literature (e.g., Molecular Cloning, A Laboratory Manual, 2nd edition, Sambrook J., Fritsch EF and Maniatis T., eds .. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989)), which are incorporated herein by reference.</span>
  </p>
  <p num="31" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">          ,     ()       80-82    VAP-1,    1 (SEQ ID N:1),    ,   ,     ,            VAP-1. ,        ,                 .</span>&nbsp;The purified nucleic acid molecules of the present invention include DNA molecules containing an open reading frame (OPC) with the position of the initiating codon in the region 80-82 on the nucleotide sequence VAP-1 shown in figure 1 (SEQ ID NO: 1), as well as DNA molecules , which include a sequence fundamentally different from that described above, but which, due to the degeneracy of the genetic code, can encode VAP-1 protein. Undoubtedly, the genetic code is well known to specialists in this field, and for specialists with an average level of knowledge in this field, obtaining pronounced variants is a routine procedure.</span>
  </p>
  <p num="32" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">            ,   ,     VAP-1.    ,      -.  " "       ,       (Genes II, Lewin . , ed., John Wiley &amp; Sons, New York (1985)). ,     ,       ,  .</span>&nbsp;Further, the present invention relates to variants of the nucleic acid molecules of the present invention, which encode parts, analogs or derivatives of the VAP-1 protein. Variants may be natural, such as natural allelic or splicing variants. By "allelic variant" is meant one of several alternative forms of a gene occupying a specific locus on the chromosome of an organism (Genes II, B. Lewin, ed., John Wiley &amp; Sons, New York (1985)). Variants not found in the natural state can be obtained using mutagenesis techniques known to those skilled in the art.</span>
  </p>
  <p num="33" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">    ,     ,   . ,         .       ,       .             ,   .       ,   ,         VAP-1   .           .</span>&nbsp;Such options include forms obtained by the substitution of nucleotides, deletions or insertions. Substitutions, deletions or insertions may include one or more nucleotides. Variants may include changes in coding regions, non-coding regions, or in both types of regions. Changes in coding regions may result in conservative or non-conservative amino acid substitutions, deletions, or insertions. Among these, silent substitutions, insertions, and deletions that do not alter the properties and activity of the VAP-1 protein or parts thereof are particularly preferred. Also particularly preferred in this regard are conservative substitutions.</span>
  </p>
  <p num="34" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">          ,   ,   , ,   ,  90%   ,   ,  95, 96, 97, 98  99% ()   ,  ,   ,    1 (SEQ ID NO:2); ()   ,    VAP-1    VAP-1,    1 (SEQ ID N:1); ()   ,   VAP-1,   ,    VAP-1,     No. DSM 11536; ()   ,      VAP-1,     No. DSM 11536; ()   ,   ,    VAP-1,    (), (), ()  (); ()   ,   ,           ()  ()      ,  ()   ,   ,     ()   VAP-1,   , ,   ,  90%    VAP-1,    1 (SEQ ID NO: 2).      ,      VAP-1 .          ,  VAP-1 ,         ,     , ,             ().      ,   , ,   ,  90, 95, 96, 97, 98  99%    VAP-1,    1 (SEQ ID N:1),     VAP-1  ,    ,   VAP-1 .</span>&nbsp;Other embodiments of the present invention include purified nucleic acid molecules that contain a polynucleotide having a nucleotide sequence at least 90% identical, and more preferably at least 95, 96, 97, 98 or 99% (a) a nucleic acid molecule encoding a polypeptide comprising the amino acid sequence shown in figure 1 (SEQ ID NO: 2); (b) a nucleic acid molecule comprising the VAP-1 coding sequence from the VAP-1 nucleotide sequence shown in Figure 1 (SEQ ID NO: 1); (c) a nucleic acid molecule encoding a VAP-1 polypeptide comprising the amino acid sequence encoded by the VAP-1 cCNA clone stored in the depository under No. DSM 11536; (d) a nucleic acid molecule comprising the coding sequence of the nucleotide sequence of VAP-1 stored in the depository under No. DSM 11536; (e) a nucleic acid molecule comprising a nucleotide sequence complementary to the nucleotide sequences of VAP-1 shown in points (a), (b), (c) or (d); (f) a nucleic acid molecule comprising a nucleotide sequence that differs from the coding sequence of a nucleic acid molecule in (b) or (d) due to the degeneracy of the genetic code, and (g) a nucleic acid molecule comprising a nucleotide sequence that hybridizes with molecule (d) and encodes a VAP-1 having an amino acid sequence that at least 90% demonstrates the identity of the VAP-1 sequence shown in figure 1 (SEQ ID NO: 2). The specified property does not depend on whether the VAP-1 polypeptide encoded by them has activity. Since even if a given nucleic acid molecule does not encode a polypeptide having VAP-1 activity, any person of ordinary skill in the art will know how to use a nucleic acid molecule, for example, as a hybridization probe or as a primer in a polymerase chain reaction (PCR) . Preferred are nucleic acid molecules that have sequences identical to at least 90, 95, 96, 97, 98, or 99% of the VAP-1 nucleic acid sequence shown in FIG. 1 (SEQ ID NO: 1), or a VAP-1 nucleic acid sequence of a deposited cDNA that actually encodes a polypeptide having the activity of a VAP-1 protein.</span>
  </p>
  <p num="35" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">   ",   , ,   , ,  90% ""   ,   VAP-1", ,       ,   ,            100    ,  VAP-1 .   ,       ,   ,  90, 95, 96, 97, 98  99%, ,   VAP-1,    1 (SEQ ID N:1),      ,           ,   Bestfit program (Wisconsin Sequence Analysis Package, Version 8 for Unix, Genetics Computer Group, University Research Park, 575 Science Drive, Madison, WI 53711).</span>&nbsp;By the phrase polynucleotide having a nucleotide sequence that is at least 90% identical to the standard nucleotide sequence encoding the VAP-1 polypeptide is meant that the nucleotide sequence of the polynucleotide is identical to the standard sequence, except that the polynucleotide the sequence may include up to ten point mutations for every 100 nucleotides of the standard nucleotide sequence encoding the VAP-1 polypeptide. In the case where the molecule of any particular nucleic acid is at least 90, 95, 96, 97, 98, or 99% identical, for example, the nucleotide sequence of VAP-1 shown in FIG. 1 (SEQ ID NO: 1), or the nucleotide sequence of a clone of deposited cDNA, it can be determined in the traditional way using known computer programs such as the Bestfit program (Wisconsin Sequence Analysis Package, <figure-callout id="8" label="Version" filenames="00000008.png,00000011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Version</a></figure-callout> 8 for Unix, Genetics Computer Group, University Research Park, 575 Science Drive, Madison, WI 53711 )</span>
  </p>
  <p num="36" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">   -<br class="style-scope patent-text">      ,        , -,        ,  VAP-1,     VAP-1       .</span>Vectors and host cells <br class="style-scope patent-text"> The present invention also relates to vectors that include the purified DNA molecules of the present invention, host cells that have been genetically engineered using DNA encoding VAP-1, and to the preparation of VAP-1 polypeptides or fragments thereof using a recombinant technique.</span>
  </p>
  <p num="37" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">      ,   ,    -.         ,           .     ,     in vitro          -  .           ,           . coli   .</span>&nbsp;Polynucleotides can be coupled to a vector containing a selectable marker for propagation in the host cell. In general, a plasmid vector is introduced as a precipitate, such as a calcium phosphate precipitate, or in combination with a charged lipid. If the vector is a virus, it can be assembled in vitro using an appropriate assembly cell line and transferred to the host cells by transduction. Selectable markers include dihydrofolate reductase or neomycin resistance to eukaryotic cell cultures, or the presence of tetracycline or ampicillin resistance genes in cultures of E. coli and other bacteria.</span>
  </p>
  <p num="38" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">   ,  -      .  -       -             -.             ,     /       .            ,        ,     .</span>&nbsp;Preferred are vectors comprising cis-active control regions with respect to polynucleotides of interest. Corresponding trans-active factors can also be introduced into the host cell using the complement vector or the vector itself when it is introduced into the host cell. In some preferred embodiments of this invention, the vectors provide specific expression, which may be inducible and / or specific for one or another type of cell. Particularly preferred among them are vectors that are inducible by environmental factors, which can be easily manipulated using factors such as temperature and food additives.</span>
  </p>
  <p num="39" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  ,    ,  ,   ,   ,  ,     , ,  ,   , ,   , ,  , ,   ,    ,   ,    ,     .</span>&nbsp;The expression vectors used in the present invention include vectors derived from chromosomes, episomes and viruses, for example vectors derived from bacterial plasmids, bacteriophage, yeast episomes, chromosomal elements of yeast, viruses such as baculoviruses, papovaviruses, vaccinia viruses, adenoviruses, smallpox viruses of birds, pseudorabies viruses and retroviruses, as well as vectors derived from their combinations, such as cosmids and phagemids.</span>
  </p>
  <p num="40" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> -      ,      <sub class="style-scope patent-text">L</sub>,  . coli lac, trp  tac,     SV40,          (LTR),    .        .         ,  ,     -       .    ,   ,            (UAA, UGA  UAG),      .</span>The DNA insert must be operably linked to a suitable promoter, such as the Lambda phage R <sub class="style-scope patent-text">L</sub> promoter, E. coli lac, trp and tac promoters, early and late SV40 promoters, as well as long term retroviral promoters (LTRs), which can be called some. Other suitable promoters are known to those skilled in the art. Expressed constructs should also contain sites for initiation of transcription, its termination, and in transcribed regions, binding sites with ribosomes for translation. The coding portion of mature transcripts expressed by these constructs preferably includes a translation initiation site at its beginning and a termination codon (UAA, UGA or UAG) located at the end of the coding sequence, respectively.</span>
  </p>
  <p num="41" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ,    ,    ,      . (Treco et al., WO 94/12650  Treco et al. , WO 95/31560),        ,         VAP-1     .    (, )            VAP-1.</span>&nbsp;Recombinant DNA technology also includes recombination techniques described by Treko et al. (Treco et al., WO 94/12650 and Treco et al., WO 95/31560), which are incorporated herein by reference, and these methods can be used to alter VAP-1 expression and aminoxidase activity in cells. Specific regulatory regions (e.g., promoters) can be introduced into the host genome in order to alter the expression of endogenous VAP-1.</span>
  </p>
  <p num="42" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  ,             -1  (VAP-1), : ()      , : (i)   VAP-1  (ii)  ,     VAP-1,  ()     ,            VAP-1.       ,    VAP-1    .</span>&nbsp;Thus, the invention relates to a method for producing a recombinant host cell with altered expression of vascular adhesion protein-1 (VAP-1), comprising: (a) introducing into the host cell a DNA construct comprising: (i) the target sequence of VAP-1 and (ii ) the regulatory sequence associated with the target sequence of VAP-1, and (b) placing the host cell in conditions suitable for the implementation of homologous recombination between the DNA construct and the endogenous sequence of VAP-1. The invention also relates to a recombinant host cell in which the expression of VAP-1 is altered by the above method.</span>
  </p>
  <p num="43" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">         VAP-1  , ,   VAP-1  ,                .   VAP-1              .    -        ,        VAP-1,   ,         ,        ,      ,    ,           .             ,      .</span>&nbsp;The invention also relates to a method for altering VAP-1 gene expression by, for example, activating VAP-1 expression in a cell that normally does not or normally does not express under desirable environmental or hormonal conditions. Changing the expression of VAP-1 may also include the use of the sequence of the present invention for the purpose of inactivating the expression of the native gene. Homologous recombination or site-directed action is used to replace or disrupt the regulatory region, under normal conditions, associated with the endogenous VAP-1 gene, with a regulatory sequence that leads to gene expression at a higher level than occurs in the corresponding untransfected cells, or creates a picture of gene expression that differs from that observed in the corresponding untransfected cells in terms of regulation and induction. In this regard, the invention relates to a method for producing proteins by activating an endogenous gene that encodes a desired product in cells.</span>
  </p>
  <p num="44" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">     ,   ,   ,       .        . (Treco et al., WO 94/12650,  Treco et al., WO 95/31560),       ,    ,        - .         ,         .     ,      ,      .</span>&nbsp;If the target is a DNA construct, it should include at least the target sequence and preferably also the regulatory sequence. As described by Treko et al. (Treco et al., WO 94/12650, and Treco et al., WO 95/31560), often add other components of the construct, such as selectable markers, amplifiable markers or exon and unrelated splicing donor sites. DNA in this design can be considered as exogenous DNA that is introduced into the host cell according to the method of the present invention. Exogenous DNA may contain sequences identical or different from the endogenous DNA that was present in the cell prior to transfection.</span>
  </p>
  <p num="45" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">          ,          ,   VAP-1   VAP-1.    , ,  ,    VAP-1,                 . () () ()     VAP-1,      .</span>&nbsp;The target sequence or DNA construct sequences are DNA sequences that allow for homologous recombination in the genome of a selected cell containing the VAP-1 gene at the VAP-1 locus. Target sequences are, for example, DNA sequences homologous to VAP-1 DNA sequences that are normally present in the genome of the obtained cells and are located mainly at both ends of the regulatory sequence. The target sequence (s) to be used are selected based on the VAP-1 site into which the DNA construct is to be inserted.</span>
  </p>
  <p num="46" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">           , ,         ,   ,        .</span>&nbsp;The regulatory sequence of the DNA construct may consist of one or more promoters, enhancers, sites of contact with the supporting structure or sites of attachment of the matrix, negative regulatory elements, binding sites with transcription factors, or combinations thereof.</span>
  </p>
  <p num="47" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">           VAP-1   ,  ,   ,     VAP-1.  ,      VAP-1,                 ,          .         ,   ,            ,         .            ,            .               ,   ,     VAP-1,     VAP-1.       -    ,     VAP-1,      VAP-1 in vitro,       in vivo  VAP-1 (,   ).</span>&nbsp;The site of introduction of the DNA sequence is mainly located inside the endogenous VAP-1 gene either in the direction opposite to transcription or in the site that affects the function of the VAP-1 gene. DNA sequences that alter the expression of the endogenous VAP-1 gene can be introduced into the host cell as a single DNA construct or as separate DNA sequences that transform into a physically bound state in the genome of the transfected cell. In this case, the DNA can be introduced in the form of linear, double double-stranded DNA, in the presence of single-stranded sections at one or both ends or without them, or the DNA can be introduced in the form of circular DNA. After the introduction of regulatory DNA into the host cell, the specified cell is placed in conditions suitable for the implementation of homologous recombination between genomic DNA and part of the introduced DNA. Homologous recombination between genomic DNA and introduced DNA results in a homologous recombinant host cell, in which sequences that alter the expression of the endogenous VAP-1 gene are operatively linked to the VAP-1 gene. The homologous recombinant host cells obtained by this method can be cultured under conditions suitable for expression of the VAP-1 protein, which leads to the production of the VAP-1 protein in vitro, or the cells can be used for in vivo delivery of the VAP-1 protein (for example, with gene therapy).</span>
  </p>
  <p num="48" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">         ,    VAP-1      (,          ,     ).         ,       .        ; ,                 ,   ,       ,       .</span>&nbsp;A targeted procedure can be a simple introduction of a regulatory sequence, placing the endogenous VAP-1 gene under the control of a new regulatory sequence (for example, by inserting a promoter or enhancer or both of them in the reverse direction of transcription of the endogenous gene). The targeted procedure may be a simple deletion of a regulatory element, such as a deletion of a tissue-specific negative regulatory element. A focused procedure can lead to the replacement of an existing element; for example, a tissue-specific enhancer can be replaced by another enhancer with a broader or different cell type specificity than natural elements, or with a different pattern of regulation or induction than that found in the corresponding untransfected cell.</span>
  </p>
  <p num="49" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">            VAP-1  ,    ,    ,  - .     ,        ,      VAP-1         () ,     ,    .</span>&nbsp;Targeted gene effects can be used to replace an existing VAP-1 regulatory region with a regulatory sequence isolated from another gene or a new regulatory sequence synthesized by genetic engineering methods. In accordance with this method, the introduction of exogenous DNA leads to disruption of endogenous sequences that control the expression of the endogenous VAP-1 gene, either by replacing all or part of the endogenous (genomic) sequence, or by means of another type of effect that disrupts the functioning of the endogenous sequence.</span>
  </p>
  <p num="50" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  ,       ,   ,    ,         ,    ,      VAP-1.     .      ,       (Treco et al. , WO 94/12650,  Treco et al., WO 95/31560),        .</span>&nbsp;DNA constructs that include exogenous DNA and optionally a DNA encoding a selectable marker, together with additional sequences necessary for the expression of exogenous DNA in recipient host cells, are used to transfect cells in which it is planned to change the production of VAP-1. In the works of Treko et al. describes in more detail homologous recombination methods used to alter the expression of an endogenous gene (Treco et al., WO 94/12650, and Treco et al., WO 95/31560), which are incorporated herein by reference.</span>
  </p>
  <p num="51" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">             ,  , , , , ,   ,   ,     ,   -.        (  Davis et al. , Basic Methods In Molecular Biology (1986)).         ,      , , ,    ,    .</span>&nbsp;DNA or recombinant constructs can be introduced into cells using various methods, including transformation, transfection, electroporation, microinjection, transduction, precipitation with calcium phosphate, as well as transfection, which is associated with the participation of liposomes, polybrene or DEAE-dextran. These methods are described in many laboratory manuals (such as Davis et al., Basic Methods In Molecular Biology (1986)). Alternatively, infectious vectors such as retroviruses, herpes, adenovirus, adenovirus-related factor, mumps and poliovirus can be used to introduce the DNA construct.</span>
  </p>
  <p num="52" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">     ,   ,  ,    E.coli, Streptomyces  Salmonella typhimurium,  ,    ,  ,    Drosophila S2  Spodoptera Sf9,  ,      CRL 1998 (     ),   , COS  Bowes,    .              .</span>&nbsp;Examples of suitable host cells include, but are not limited to, bacterial cells such as E. coli, Streptomyces and Salmonella typhimurium cells, fungal cells such as yeast cells, insect cells such as Drosophila S2 and Spodoptera Sf9 cells, animal cells such as Ah and CRL 1998 cells (both species are endothelial cells), CHO, COS and Bowes melanoma cells, as well as plant cells. Appropriate culture media and culture conditions for the host cells described above are known in the art.</span>
  </p>
  <p num="53" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">           .</span>&nbsp;Suitable prokaryotic and eukaryotic cells are well known to those skilled in the art.</span>
  </p>
  <p num="54" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">   ,      ,   . coli  lacZ, T3  7 ,  gpt,   P<sub class="style-scope patent-text">R</sub>  P<sub class="style-scope patent-text">L</sub>,    trp.       CMV,   HSV,     SV40,         (LTR),       (RSV),   ,   -1  .</span>Known bacterial promoters suitable for use in the present invention include the E. coli and lacZ, T3 and T7 promoters, the gpt promoter, the lambda promoters P <sub class="style-scope patent-text">R</sub> and P <sub class="style-scope patent-text">L</sub> , as well as the trp promoter. Suitable eukaryotic promoters include the CMV early promoter, HSV thymidine kinase promoter, SV40 early and late promoters, RNA long repeat promoters at the ends of the retrovirus genome (LTR), such as the Routh sarcoma virus (RSV), and metallothionein promoters such as 1 mice.</span>
  </p>
  <p num="55" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  ,   VAP-1 <br class="style-scope patent-text">  ,            .    -  ,    10  300    ,           .     SV40,            100  270 ..,    ,  ,       ,   .</span>Transcription of DNA encoding a VAP-1 polypeptide according to <br class="style-scope patent-text"> of the present invention, higher eukaryotes can be enhanced by inserting an enhancer sequence into a vector. Enhancers are cis-active DNA elements, usually 10 to 300 nucleotide pairs in length, which can enhance the transcriptional activity of the promoter in this type of host cell. Examples of enhancers include the SV40 enhancer, which is located on the late side of the replication initiation site in the region from 100 to 270 bp, the cytomegalovirus early promoter enhancer, the polyoma enhancer, located on the late side of the replication initiation site, and adenovirus enhancers.</span>
  </p>
  <p num="56" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  VAP-1     ,    ,       ,      . , ,       ,     ,  N-  VAP-1                 .  ,      VAP-1     .           .            ,                ,     .</span>&nbsp;The VAP-1 polypeptide may be expressed in a modified form, such as a fusion protein, and may include not only secretion signals, but also additional heterologous functional sites. So, for example, a section of additional amino acids, in particular of charged amino acids, can be added to the N-terminus of the VAP-1 polypeptide to improve stability and persistence in the host cell during cleaning or during subsequent work and storage. In addition, peptide moieties can be added to VAP-1 polypeptide to facilitate purification. Such sites can be removed at the final stage before obtaining the polypeptide. Adding peptide moieties to polypeptides to impart secretion or excretion, to improve stability and to facilitate purification is a well-known and routine procedure, among others, used for this purpose.</span>
  </p>
  <p num="57" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  VAP-1             ,      ,  , -   ,   , ,    ,  ,       .        ,     ,           , , ,  , ,  ,   .      ,     ,           .</span>&nbsp;VAP-1 protein can be isolated and purified from recombinant cell cultures using known methods, including precipitation with ammonium sulfate or ethanol, acid extraction, anion or cation exchange chromatography, chromatography on phosphocellulose, chromatography based on hydrophobic interaction, affinity chromatography, chromatography on hydroxylapatite and chromatography on lectin. The polypeptides of the present invention include naturally purified products, products of chemical synthesis and products obtained using recombinant techniques from prokaryotic or eukaryotic host cells, including, for example, cells of bacteria, yeast, higher plants, insects and mammals. Depending on the nature of the host cell used in the recombinant production procedure, the polypeptides of the present invention may be glycosylated or non-glycosylated products.</span>
  </p>
  <p num="58" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  VAP-1   <br class="style-scope patent-text">      1 (SEQ ID N:1)    VAP-1    ,    763  ,    1 (SEQ ID N:2),       80-82  ,    1 (SEQ ID N:1),     84,6 .   6   N-  3   O-      (.1) (       O-  E-mail NetO-glic@cbs.dtu.dk (Hansen et al., Biochem. J., 308:801-813 (1995)).</span>VAP-1 polypeptides and fragments thereof <br class="style-scope patent-text"> The nucleotide sequence of the VAP-1 cDNA established and shown in FIG. 1 (SEQ ID NO: 1) contains an open reading frame encoding the protein of the 763 amino acid residues shown in FIG. 1 (SEQ ID NO: 2), with the position of the initiation codon in region 80 -82 nucleotide sequence shown in figure 1 (SEQ ID NO: 1), which is characterized by a molecular weight of 84.6 kDa. The protein has 6 potential N-glycosylation sites and 3 putative O-glycosylation sites per monomer (Fig. 1) (determination was made using the E-mail server NetO-glic@cbs.dtu.dk for forecasting the O-glycosylation site ( Hansen et al., Biochem. J., 308: 801-813 (1995)).</span>
  </p>
  <p num="59" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  ,        VAP-1,   ,   ,   ,    1 (SEQ ID NO: 2),     ,    .  ""  ""    (   ),                   , ,   ,  ,   .</span>&nbsp;Thus, the present invention also relates to a purified VAP-1 polypeptide having the amino acid sequence encoded by the deposited cDNA or the amino acid sequence shown in FIG. 1 (SEQ ID NO: 2), or to a peptide or polypeptide comprising a portion of the above polypeptides. The terms peptide and oligopeptide are considered synonyms (as is commonly accepted), and each of these terms can be used for any of the described cases, depending on the context, to indicate a chain containing at least two amino acids linked by a peptide bond .</span>
  </p>
  <p num="60" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">   ,      VAP-1            .  ,       VAP-1,     VAP-1.    , , ,     .    ""         . ,  ,         (,        ),       . (Bowie J. U. et al. , Science, 247:1306-1310 (1990)).       , ,    ,            VAP-1.</span>&nbsp;It is known in the art that certain amino acid sequences of a VAP-1 polypeptide can be changed without seriously affecting the structure or function of the protein. Thus, the present invention also includes VAP-1 polypeptide variations that exhibit significant VAP-1 activity. Such mutants include deletions, insertions, inversions, repeats and substitutions of similar residues. Small changes in such neutral amino acid substitutions generally have little effect on activity. Rules to determine which amino acid changes are likely to be phenotypically silent (for example, should not have a pronounced harmful effect on function) can be found in the work of Bowie et al. (Bowie J. U. et al., Science, 247: 1306-1310 (1990)). The changes are preferably of a minor nature and relate, for example, to substitutions of conserved amino acids, which do not significantly affect the folding or activity of the VAP-1 protein.</span>
  </p>
  <p num="61" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">    VAP-1   ,     ,       ,   -    .         ,       .</span>&nbsp;The amino acids in the VAP-1 protein of the present invention, which are necessary for its functioning, can be determined by methods known in the art, such as site-directed mutagenesis and deletion analysis. The resulting mutant molecules are then tested for the presence of biological activity, such as aminoxidase activity or adhesive function.</span>
  </p>
  <p num="62" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">         .      VAP-1     , ,    ,       (Smith and Johnson, Gene, 67:31-40 (1988)).</span>&nbsp;The polypeptides of the present invention are preferably presented in purified form. The recombinantly produced version of the VAP-1 polypeptide can be substantially purified, for example, using the one-step procedure described by Smith and Johnson (Smith and Johnson, Gene, 67: 31-40 (1988)).</span>
  </p>
  <p num="63" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">      ,  ,   ,  90% ,  ,   ,  95%     ,   ,  96, 97, 98  99%    .       , ,   ,  90%,  , ,   ,  90  95%,    , ,   ,  96, 97, 98  99%  VAP-1,   ,   VAP-1,    1 (SEQ ID NO:2),      , ,   , 30 ,   ,   , 50 .</span>&nbsp;The polypeptides of the present invention include polypeptides that have at least 90% similarity, more preferably at least 95% similarity and even more preferably at least 96, 97, 98 or 99% similarity the above polypeptides. Other polypeptides of the present invention include polypeptides identical to at least 90%, more preferably identical to at least 90 or 95%, and even more preferably identical to at least 96, 97, 98 or 99% of the VAP-1 polypeptide encoded by the deposited cDNA or the VAP-1 polypeptide shown in Figure 1 (SEQ ID NO: 2), and also include portions of such polypeptides containing at least 30 amino acids, and more preferably at least 50 amino acids.</span>
  </p>
  <p num="64" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  ,   ,   , ,  90% ""    VAP-1, ,       ,   ,             100       VAP-1.</span>&nbsp;By a polypeptide having an amino acid sequence of at least 90% identical to the standard amino acid sequence of VAP-1, it is meant that the amino acid sequence of the polypeptide is identical to the standard sequence, except that the polypeptide sequence may include up to ten amino acid changes for every 100 amino acids in the standard amino acid set of the VAP-1 polypeptide.</span>
  </p>
  <p num="65" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">             ,       VAP-1      ,       VAP-1.         VAP-1       (Salmi . and Jalkanen S., Science, 257: 1407-1409 (1992),    NoNo. 5512442  5580780       No. 08/447799,        . ,         (Fields and Song, Nature, 340:245-246 (1989))  "" ,   VAP-1,           .</span>&nbsp;The polypeptides of the present invention can also be used to increase the production of monoclonal antibodies that are used to detect expression of the VAP-1 protein or as agonists or antagonists capable of enhancing or inhibiting the functioning of the VAP-1 protein. The procedure for increasing the production of monoclonal antibodies against VAP-1 is described in more detail in the work of Salmi and Jalkanen (Salmi M. and Jalkanen S., Science, 257: 1407-1409 (1992), in US patents Nos. 5512442 and 5580780 and in the patent application US No. 08/447799, which are incorporated herein by reference. Further, such polypeptides can be used in the double-hybrid yeast system (Fields and Song, Nature, 340: 245-246 (1989)) to "capture" protein binding proteins VAP-1, which may also be the agonists and antagonists of the present invention.</span>
  </p>
  <p num="66" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">      "" (AT)  " " (MAT)   ,     (, ,  Fab  F(ab')<sub class="style-scope patent-text">2</sub> ),      VAP-1.  Fab  F(ab')<sub class="style-scope patent-text">2</sub>   Fc   ,     ,             ,    (Wahl et al., J. Nucl. Med., 24:316-325 (1983)).  ,    .</span>In the context of the present invention, the term antibody (AT) or monoclonal antibody (MAT) includes intact molecules as well as antibody fragments (such as, for example, Fab and F (ab ') <sub class="style-scope patent-text">2</sub> fragments) that are capable of specifically binding a VAP protein -1. Fragments Fab and F (ab ') <sub class="style-scope patent-text">2</sub> do not contain an Fc fragment of an intact antibody, which is more rapidly excreted from circulation, and therefore may have less ability to bind to non-specific tissues than an intact antibody (Wahl et al., J. Nucl. Med ., 24: 316-325 (1983)). Thus, these fragments are preferred.</span>
  </p>
  <p num="67" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">            . , , ,   VAP-1    ,          ,   .         VAP-1         .               .</span>&nbsp;Antibodies of the present invention are obtained using any of a variety of methods. For example, cells expressing a VAP-1 protein or antigenic fragment thereof can be introduced into an animal to induce the formation of serum containing polyclonal antibodies. In a preferred method, VAP-1 protein is prepared and purified to produce a substantially free of natural contamination preparation. Then, such a preparation is introduced into the animals body to produce polyclonal antiserum with a higher specific activity.</span>
  </p>
  <p num="68" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">              (  ,    VAP-1).           (Kohler et al., Nature 256:495 (1975); Kohler et al., Eur. J. Immunol., 6:511 (1976); Kohler et al., Eur. J. Immunol. , 6:292 (1976); Hammerling et al., In:Monoclonal Antibodies and T-Cell Hybridomas, Elsevier, N.Y. (1981), pp.563-681).</span>&nbsp;In the most preferred method, the antibodies of the present invention are monoclonal antibodies (or fragments thereof binding to the VAP-1 protein). Such monoclonal antibodies can be obtained using the hybridoma technique (Kohler et al., Nature 256: 495 (1975); Kohler et al., Eur. J. Immunol., 6: 511 (1976); Kohler et al., Eur. J. Immunol., 6: 292 (1976); Hammerling et al., In: Monoclonal Antibodies and T-Cell Hybridomas, Elsevier, NY (1981), pp. 563-681).</span>
  </p>
  <p num="69" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">    ,  Fab, F(ab')<sub class="style-scope patent-text">2</sub>              ,    .            ,    (  Fab )   (  F(ab')<sub class="style-scope patent-text">2</sub> ).       VAP-1            .</span>It should be borne in mind that Fab, F (ab ') <sub class="style-scope patent-text">2</sub> and other antibody fragments of the present invention can also be used in accordance with the methods disclosed in the present description. Such fragments are typically obtained by proteolytic cleavage using enzymes such as papain (to produce Fab fragments) or pepsin (to produce F (ab ') <sub class="style-scope patent-text">2</sub> fragments). Alternative fragments for binding to the VAP-1 protein can be obtained using recombinant DNA techniques or chemical synthesis methods.</span>
  </p>
  <p num="70" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ""          ,     ,     .        (.  Morrison, Science, 229:1202 (1985); Oi et al., BioTechniques, 4:214 (1986); Cabilly et al.   No. 4816567; Taniguchi et al., EP 171496.</span>&nbsp;"Humanized" chimeric monoclonal antibodies can be obtained using genetic constructs derived from hybridoma cells producing the monoclonal antibodies described above. Methods for producing chimeric antibodies are known in the art (see Morrison, Science, 229: 1202 (1985); Oi et al., BioTechniques, 4: 214 (1986); Cabilly et al. U.S. Patent No. 4816567; Taniguchi et al. EP 171496.</span>
  </p>
  <p num="71" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  VAP-1<br class="style-scope patent-text"> VAP-1          ,   -  (     1.4.3.6).  VAP-1,    1 (SEQ ID NO:2),   24%  Cu- Escherichia coli    41-81%       .            (81%).    -   ()         VAP-1  ,     .      -     ,  VAP-1    .</span>Using VAP-1 <br class="style-scope patent-text"> VAP-1 of the present invention has a significant level of identity with the family of enzymes related to copper-containing aminoxidases (EC classification code 1.4.3.6). The VAP-1 protein shown in FIG. 1 (SEQ ID NO: 2) is approximately 24% identical to Escherichia coli Cu-aminoxidase and approximately 41-81% similar to members of this family in mammals. The highest level of identity is shown when compared with bovine serum aminoxidase (81%). Using benzylamine, a substrate of monoamine oxidase (MAO), a significant enzymatic activity of aminoxidase was detected in CHO VAP-1 expressing cells, but not in pseudotransfected cells. In the presence of copper-containing monoamine oxidase inhibitors - semicarbazide and hydroxylamine, it was shown that VAP-1 is not active against benzylamine.</span>
  </p>
  <p num="72" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  , ,     ,            VAP-1,   .  , ,        .  ,          ,   .     .</span>&nbsp;Thus, the peptides encoded by the DNA of the present invention can be used for enzymatic oxidation of an amine in the reaction of an amine with a VAP-1 polypeptide having aminoxidase activity. An amine may, for example, belong to a number of endogenous and xenobiotic aromatic amines. In addition, the amine may relate to certain endogenous and xenobiotic aliphatic amines, such as methylamine. Preferably, the amine is benzylamine.</span>
  </p>
  <p num="73" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">                   .   ,  0,2-5 ,    ,  0,5 ,  -     0,05-0,2 ,  0,1 .       1-100 ,  80 ,   <sup class="style-scope patent-text">14</sup>-,     0,1-1,0 Ci,  0,4 Ci.         0,05-0,5 ,  0,1 .    37<sup class="style-scope patent-text">o</sup>   1       ,  0,1-05 /,  0,35 /, .        / .    (  )   <sup class="style-scope patent-text">14</sup>     .</span>The conditions for determining aminoxidase activity when using benzylamine as an aminoxidase substrate are described in detail below in the Materials and Methods section. In a final volume of 0.2-5 ml, preferably in a final volume of 0.5 ml, sodium phosphate buffer is added to a final concentration of 0.05-0.2 mM, preferably 0.1 mM. Unlabeled benzylamine is then added to a concentration of 1-100 nmol, preferably 80 nmol, and <sup class="style-scope patent-text">14</sup> C-benzylamine is added so that the activity is 0.1-1.0 Ci, preferably 0.4 Ci. For the test, a cell lysate sample of 0.05-0.5 ml, preferably 0.1 ml, is added. After incubation at 37 <sup class="style-scope patent-text"> C.</sup> for 1 hour, the aldehyde product of the aminoxidase reaction is extracted with toluene containing 0.1-05 g / l, preferably 0.35 g / l, of diphenyloxazole. Additional extraction may be carried out using a toluene / diphenyloxazole mixture. In the first extraction (and second extraction), the level of <sup class="style-scope patent-text">14</sup> C of radioactivity in a liquid scintillation counter is determined.</span>
  </p>
  <p num="74" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ,  ,       VAP-1      .    , , , , , , , , , , 3,5--4-  MDL72145 (()-2-(3,4))-3-),    .      10-1000      ,   50-1000  80-500 ,    100 .      0,1-100      ,   1-10   2-8 ,    5 .</span>&nbsp;The invention further relates to a method for inhibiting the aminoxidase activity of VAP-1 by administering an effective amount of an aminoxidase inhibitor. The inhibitor can be, for example, semicarbazide, hydroxylamine, propargylamine, isoniazad, nialamide, hydralazine, procarbazine, monomethylhydrazine, 3,5-ethoxy-4-aminomethylpyridine or MDL72145 ((E) -2- (3,4) dimethoxyphenyl) -3 -fluoroallyl amine), preferably semicarbazide or hydroxylamine. Semicarbazide may be administered at a concentration of 10-1000 M or in another concentration range, such as 50-1000 or 80-500 M, preferably at a concentration of 100 M. Hydroxylamine can be administered at a concentration of 0.1-100 M or in another concentration range, such as 1-10 M or 2-8 M, preferably at a concentration of 5 M.</span>
  </p>
  <p num="75" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">         ,   -1  (VAP-1),            .         -   .      in vitro  in vivo.</span>&nbsp;In the framework of the present invention, the binding of endothelial cells to lymphocytes mediated by vascular adhesion protein-1 (VAP-1) can be modified by introducing an aminoxidase inhibitor or enhancer into the host cell. A host cell may be a mammalian cell line  a human or animal. The invention can be used for treatment in vitro or in vivo.</span>
  </p>
  <p num="76" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">       ,              .</span>&nbsp;The general description of the invention is illustrated by the following examples, which are given only for the purpose of illustrating it and in no way limit the present description.</span>
  </p>
  <p num="77" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  1<br class="style-scope patent-text">   VAP-1<br class="style-scope patent-text">    ,   VAP-1  ,   ,    ,        VAP-1 .       b         VAP-1  90  170-180                V8.  ,    N-  VAP-1  90 .      ,        VAP-1, ,       , ,     ,   2   90 .</span>Example 1 <br class="style-scope patent-text"> Isolation of VAP-1 cDNA <br class="style-scope patent-text"> Smooth muscles of the human gut, in which VAP-1 is highly expressed, are obtained from material selected during surgical procedures, using it as a source for further purification of the VAP-1 protein. On an immunoaffinity column with a monoclonal antibody MAb, detergent-treated smooth muscle lysates cleaned VAP-1 forms of <figure-callout id="90" label="size" filenames="00000004.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">size</a></figure-callout> 90 and 170-180 kDa in sufficient quantities to determine the internal peptide sequence after cleavage with trypsin and protease V8. In addition, direct sequencing of the N-terminus of the VAP-1 region of 90 kDa was performed. The elution profile of the peptide from the HPLC column used to purify peptides from both forms of VAP-1 is identical, as are the peptide sequences at the corresponding peaks, indicating that the protein is a dimer consisting of 2 subunits of 90 kDa.</span>
  </p>
  <p num="78" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">     VAP-1            -   ,      .      700 ..        pUC18    .       ,   ,          ,    V8,     ,      .          10          ,    VAP-1,  ,   ,      VAP-1,    .              .       2501 . . ,        2292 . .,     ,    pUC19.      ,   N-   VAP-1  90 ,     ,   VAP-1       V8,       (.1).      5'-  80 ..   3'-  129 . .,    -.  3'-       ,  - ,    ,    VAP-1   ,      .</span>&nbsp;Some of the VAP-1 peptide sequences are used to create partially degenerate oligonucleotide primers for RT-PCR experiments using mRNA obtained from the smooth muscle of the human gut. A single cDNA fragment of approximately 700 bp amplified using primers and cloned in pUC18 to determine its sequence. The cDNA sequence contains a continuous open reading frame that encodes a protein containing some of the peptide sequences from the immuno-purified material treated with trypsin and V8, and this confirms the fact that amplification affected the desired fragments of cDNA. To isolate longer cDNA clones, a set of 10 libraries of human cDNAs is analyzed by PCR to identify those that contain VAP-1 cDNAs, and libraries showing the highest signal are screened with the VAP-1 cDNA fragment obtained by PCR. In this way, many overlapping cDNA clones are isolated from cDNA libraries of the human lung and heart. 2501 bp cDNA was selected from these clones. , which contains a continuous open reading frame measuring 2292 bp starting at the methionine codon of ATG, and subcloned into pUC19. The start codon is followed by the peptide sequence found at the N-terminus of the purified VAP-1 protein of <figure-callout id="90" label="size" filenames="00000004.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">size</a></figure-callout> 90 kDa and an adjacent open reading frame encoding all VAP-1 peptides after processing with trypsin and V8, which were identified by protein sequencing (Fig. 1 ) In this clone, there is an untranslated 5  region of 80 bp in size. and an untranslated 3  region of 129 bp following the TAG stop codon. Neither the polyadenylation signal nor the poly-A sequence were detected at the 3'-end of the DNA, which suggests that the native VAP-1 mRNA may be longer than in the situation with the isolated cDNA.</span>
  </p>
  <p num="79" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">   VAP-1  COS-7 ,     ,   ,            VAP-1 b, IB2 (.2,      ,  ,  4).      (.2,      ,  ,  4).  ,     ,   ,   VAP-1,     ,   VAP-1.</span>&nbsp;Temporary expression of VAP-1 in COS-7 cells that occurs after transfection with an expression vector containing cDNA leads to strong staining of the cell surface in the cell population using VAP-1 MAb, IB2 (Fig. 2, picture of the sorting of cells by fluorescence intensity, row B, column 4). The control of transfected cells was negative (FIG. 2, picture of cell sorting by fluorescence intensity, row A, column 4). Thus, it was concluded that cDNA encoding immunoreactive VAP-1, which is expressed on the surface of cells transfected with VAP-1 cDNA, was isolated.</span>
  </p>
  <p num="80" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> VAP-1 <br class="style-scope patent-text">   ,    VAP-1,    763   84,6 .        ,  VAP-1      ,     (     1.4.3.6).      24% ,   u-  Escherichia coli,  41-81%       .           (81%),         ,      N- .  . 3    VAP-1  4     ,       .</span>VAP-1 protein <br class="style-scope patent-text"> The open reading frame contained in the VAP-1 cDNA encodes a 84.6 kDa 763 amino acid protein. A search in the database of acceptable protein sequences revealed that VAP-1 has significant identity with the family of enzymes belonging to copper-containing aminoxidases (EC enzyme classification number 1.4.3.6). The degree of identity varies from about 24% of the level characteristic of Cu-aminoxidase in Escherichia coli, to 41-81% in the case of representatives of this family in mammals. The highest identity was found when compared with bovine serum aminoxidase (81%), which showed significant conservatism over the entire length of the protein, except for a short section at the N-terminus of the molecule. In FIG. 3 shows for comparison VAP-1 and 4 other representatives of copper-containing mammalian aminoxidases, for the sequences of which there is relevant information.</span>
  </p>
  <p num="81" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> VAP-1      -                ,      ,      RGD      726-728. , ,            ,     .   6   N-  3   -      (.1) (       -  E-mail Netglic@cbs.dtu.dk (Hansen et al., Biochem. J., 308:801-813 (1995)).</span>&nbsp;VAP-1 does not demonstrate significant identity with any of the currently known adhesion molecules and does not contain any protein domains that are rarely found inside such proteins, although we noted the presence of RGD motifs in the region between residues 726-728. However, the functional significance of this commonly encountered motive in terms of binding to integrin, if this process takes place, is unknown. The protein has 6 potential N-glycosylation sites and 3 putative O-glycosylation sites per monomer (Fig. 1) (determination was made using the E-mail server Netglic@cbs.dtu.dk for forecasting the O-glycosylation site (Hansen et al., Biochem. J., 308: 801-813 (1995)).</span>
  </p>
  <p num="82" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">         ,   ,    23 ,         N- ( 5-27),    .1 (SEQ ID NO:2).          ,         19,        (von Hejine G., Nucl. Acids. Res., 14: 4683-4690 (1986)),    . N-    VAP-1  90    ,         ,   ,             .  ,  ,   ,   ,          II (Hartmann E. et al., Proc. Natl. Acad. Sci. USA, 86:5786-5790 (1989)),  N-    -   .</span>&nbsp;Examination of the protein sequence did not reveal the presence of regions with characteristics characteristic of membrane domains, with the exception of region 23 of the molecule, which consists mainly of hydrophobic amino acids at the farthest N-terminus (residues 5-27), which is shown in Fig. 1 (SEQ ID NO: 2 ) The indicated region can be interpreted either as a cleavable secretion signal, since it contains a potential cleavage site at position 19, which was established by the method of von Heine (von Hejine G., Nucl. Acids. Res., 14: 4683-4690 (1986)) , or as a transmembrane domain. The 90 kDa N-terminal VAP-1 protein sequence indicates that this hydrophobic region was not excised from the material that we purified, and is unlikely to function as a normal cleavable signal sequence for secretion. In addition, the charge of the residues flanking the hydrophobic region suggests that this may be the membrane domain of type II membrane protein (Hartmann E. et al., Proc. Natl. Acad. Sci. USA, 86: 5786-5790 (1989) ) having an N-terminus in the cytoplasm and a C-terminus in the extracellular domain.</span>
  </p>
  <p num="83" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">   ,              VAP-1  ,       VAP-1,    FLAG,    MAT M2,                .     ,    VAP-1      ,    COS-7            FLAG  VAP-1 ,   MAT M2  12 (. 2)      ,     .    MAT  FLAG      (.2,  F,  5),    VAP-1     ,      (. 2,    F,  4).       MAT   FLAG,   VAP-1 (.2,    D,  4  5).    ,  N- FLAG       ,         -  ,  MAT 12,  .         .</span>&nbsp;To determine whether this hydrophobic region can function as a transmembrane domain and determine the orientation of VAP-1 in the membrane, the authors created constructs for the expression of VAP-1 cDNA in which the FLAG epitope recognized by the commercially available MAT M2 was inserted into the reading frame after initiating methionine codon on the predicted cytoplasmic side of the putative transmembrane domain. The indicated construct and control construct, in which VAP-1 cDNA is placed in a vector in the reverse orientation, are used for transfection of COS-7 cells and the unstable expression of FLAG and VAP-1 epitopes recognized by MAT M2 and 1B2 respectively are analyzed by fluorescence intensity sorting ( Fig. 2) using for this both permeabilized and non-permeabilized cells. Staining under the influence of MAT against FLAG was observed only on permeabilized cells (Fig. 2, row F, column 5), while VAP-1 staining was observed on both the population of permeabilized and non-permeabilized cells (Fig. 2, rows C and F, column 4). Control transfected cells were negative on MAT against both FLAG and VAP-1 (FIG. 2, rows A and D, <figure-callout id="4" label="columns" filenames="00000009.png,00000011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">columns</a></figure-callout> 4 and 5). These data suggest that the N-terminus of the FLAG epitope is located on the cytoplasmic side of the cell membrane, the hydrophobic region captures the lipid bilayer and there is a large C-terminal extracellular domain recognized by MAT 1B2 blocking adhesion. All putative glycosylation sites are located in the extracellular part of the molecule.</span>
  </p>
  <p num="84" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">        VAP-1,    COS-7 ,    -   MAT 1B2     VAP-1              (.4).      VAP-1  170-180    180-190       ,   VAP-1,    VAP-1,   ,              VAP-1  -.           VAP-1   (Salmi M. and Jalkanen S., J. Exp. Med., 183:569-570(1996)).</span>&nbsp;To determine the size and glycosylation level of recombinant VAP-1, which is temporarily expressed in COS-7 cells, the authors carried out immunoblotting of separated cell extracts of VAP-1 and pseudotransfected cells in SDS-PAGE using MAT 1B2 before and after their treatment with sialidase and its absence ( figure 4). The fact of an obvious increase in the molecular weight of VAP-1 from 170-180 kDa to about 180-190 kDa during sialidase treatment indicates that recombinant VAP-1, as well as native VAP-1, are sialoglycoprotein, while reducing the negative charge by removing negatively charged sialic acids reduces the mobility of VAP-1 in SDS-PAGE. A similar effect in sialidase treatment was also observed in the case of the use of VAP-1 from tonsils (Salmi M. and Jalkanen S., J. Exp. Med., 183: 569-570 (1996)).</span>
  </p>
  <p num="85" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  VAP-1<br class="style-scope patent-text"> -  ,            , ,    VAP-1        4,2 . .. (.5).  - ,   VAP-1  4,2 . ..      .           ,     ,         .      VAP-1   ,  , , ,  , ,     .       , ,    , , ,      (.5).           .</span>Expression VAP-1 <br class="style-scope patent-text"> Northern blot analysis of mRNA isolated from the smooth muscle of the human gut and depleted in the stroma of the tonsils by lymphocytes shows that the cloned VAP-1 cDNA hybridizes in both tissues with 4.2 thousand bp mRNA. (figa). Further Northern blotting showed that 4.2 thousand bp of VAP-1 mRNA expressed in a wide range of human tissues. At the same time, the messenger is not detected in peripheral blood leukocytes or the brain, but is highly expressed in the lungs, small intestine and appendix in comparison with other tissues. And only small amounts of VAP-1 mRNA are found in the spleen, thymus, testis, liver, pancreas, kidney, bone marrow, and embryonic liver. An intermediate level of expression is noted in the prostate gland, ovary, mucous membrane of the colon, heart, placenta, skeletal muscle, and lymph node (Figure 5B). No other types of mRNA were detected even after prolonged autoradiography.</span>
  </p>
  <p num="86" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">   <br class="style-scope patent-text">   .       MAT 1B2  VAP-1  3G6  -  (Salmi M. and Jalkanen S. , Science, 257:1407-1409 (1992)). MAT M2,  FLAG  (DYKDDDDK),    Lab, Espoo, .</span>Materials and methods <br class="style-scope patent-text"> Antibodies and reagents. The literature describes murine monoclonal antibodies MAT 1B2 against VAP-1 and 3G6 against chick T cells (Salmi M. and Jalkanen S., Science, 257: 1407-1409 (1992)). MAT M2, recognizing the FLAG peptide (DYKDDDDK), obtained from KEVO Lab, Espoo, Finland.</span>
  </p>
  <p num="87" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">    VAP-1.       ,      lamina propria.               (150  NaCl, 10  -,  2,7, 1,5  MgCl<sub class="style-scope patent-text">2</sub>, 1% NP-40, 1%   1  ).           ,  5  nr-  ,    ,       MAT  VAP-1 (3 / ).       VAP-1   50  .      .           (Laemmli)    5-12,5% - .</span>Purification and sequencing of VAP-1. In abdominal surgery, normal intestinal specimens are excised, separating them from lamina propria's own lamina. The smooth muscle wall is crushed into small pieces and lysed overnight in a lysis buffer (150 mM NaCl, 10 mM Tris base, pH 2.7, 1.5 mM MgCl <sub class="style-scope patent-text">2</sub> , 1% NP-40, 1% aprotinin and 1 mM PMSF ) After clarification, the lysate supernatant is sequentially applied to immunoaffinity chromatography columns containing 5 ml of CnBr-activated Sepharose beads, including normal rat serum that does not bind to monoclonal antibodies and anti-VAP-1 MAT (3 mg / ml beads). Specific columns were washed with lysis buffer and VAP-1 antigens eluted with 50 mM triethylamine. The eluate is immediately frozen and then lyophilized. After that, the sample was dissolved in non-reducing sample buffer Laemmli and separated in 5-12.5% SDS-PAGE gel.</span>
  </p>
  <p num="88" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">      (Applied Boisystems Inc. , Foster City, CA, )           90  170-180 .    170-180      90    (  , Boehringer Mannheim GmbH, Mannheim, ),       . (Fernandez J. et al., Anal. Biochem. , 201: 255-262 (1992)).      (150; Applied Biosystems)   Vydac C<sub class="style-scope patent-text">18</sub> (2,1  150 ).  N-      (477 A; Applied Biosystems),        (120 ; Applied Biosystems).     90      N-   .        V8 (  , Boehringer Mannheim)      ,   .            -       (Lasermat, Finnigan).</span>After transferring to a polyvinylidene difluoride membrane (Applied Boisystems Inc., Foster City, CA, USA) by electroblotting, the membrane was stained with Coomassie Blue and bands of 90 and 170-180 kDa were cut. A complete band of 170-180 kDa and a portion of 90 kDa material are digested with trypsin (purity for sequencing, Boehringer Mannheim GmbH, Mannheim, Germany), as described by Fernandez et al. (Fernandez J. et al., Anal. Biochem., 201: 255-262 (1992)). The eluted peptides were separated by HPLC (150A; Applied Biosystems) on a Vydac C <sub class="style-scope patent-text">18</sub> column (2.1 x 150 mm). N-terminal sequence analysis was performed on a protein sequencer (477 A; Applied Biosystems) equipped with an online phenylthiohydantoin-based amino acid analyzer (120 A; Applied Biosystems). The remaining 90 kDa material is analyzed to determine the N-terminal sequence before cleavage. After trypsin digestion, the membranes are again digested with V8 protease (sequencing purity, Boehringer Mannheim) and the eluted peptides are purified and sequenced as described above. Sequence data for a series of peptides is confirmed using a laser desorption method of matrix mass spectrometry to confirm the predicted mass (Lasermat, Finnigan).</span>
  </p>
  <p num="89" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  - .   . coli    ,  ,  ,       ,  . coli,             (Sambrook J. et al., Molecular Cloning: A Laboratory Manual, 2nd ed. , Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. (1989)).           QIAEX (QIAEGEN, Hilden, )      .         Amersham Multiprime  [<sup class="style-scope patent-text">32</sup>-P]dCTP    3000 Ci/ (Amersham, Bucks, ).      , ,  ,  Amersham Hyperfilm .        pUC18    SweClone (Pharmacia, Uppsala, ).       Sequenase,  2.0 (United States Biochemical Corporation, Cleveland, , ),     ,       (University of Turku, Department of Medical Genetics).         Wisconsin Package,  8.1-UNIX  Genetics Computer Group.        BLAST Email  WWW        (National Center for Biotechnology Information) (http://www.ncbi.nlm.nih. gov/).            Kebo Lab (Espoo, ).     Dynazyme  (Finnzymes, Espoo, )  ,  ,         ,     . ,      VAP-1     -,   N2; gctgtgatcacmatyttygc (SEQ ID NO:3),   N- AVITIFA   VAP-1 (SEQ ID NO: 4) (  13  19   )  4; ccggccctgrtagaasac (SEQ ID NO: 5),       VFYQGR (SEQ ID NO:6) (  264  269).        : 94<sup class="style-scope patent-text">o</sup>, 1 ; 55<sup class="style-scope patent-text">o</sup>, 1 ; 72<sup class="style-scope patent-text">o</sup>, 2    30 .            Ultraspec (Biotecx, Houston, , ),     .  -      Clontech Laboratories (Palo Alto, CA, )    <sup class="style-scope patent-text">32</sup>-      .    ,       ( No. HL3004a)   ( No. HL3026a)   Clontech Laboratories.</span>Technique of molecular biological research. Isolation of small and large plasmids from E. coli, restriction enzyme digestion, plaque hybridization, lambda phage purification and phage DNA extraction, E. coli transformation, cDNA synthesis and plasmid construction are carried out in accordance with standard research techniques (Sambrook J. et al., Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989)). Isolation of DNA fragments from agarose gels was carried out using a QIAEX kit (QIAEGEN, Hilden, Germany) in accordance with the manufacturer's recommendations. DNA probes were prepared using a labeled Amersham Multiprime DNA kit and [ <sup class="style-scope patent-text">32</sup> -P] dCTP with an activity of about 3000 Ci / mmol (Amersham, Bucks, UK). Autoradiography is performed using intensifying screens, using, if necessary, Amersham Hyperfilm MP hyperfilms. PCR fragments were made blunt and cloned into pUC18 using the SweClone kit (Pharmacia, Uppsala, Sweden). Plasmid DNA is sequenced using the Sequenase kit, version 2.0 (United States Biochemical Corporation, Cleveland, OH, USA), according to the manufacturer's recommendations, or on a DNA sequencer (University of Turku, Department of Medical Genetics). Sequence assembly and analysis was performed using the Wisconsin Package, version 8.1-UNIX software at the Genetics Computer Group. Comparison of available databases is carried out using the BLAST Email or WWW server of the National Center for Biotechnology Information (http: //www.ncbi.nlm.nih. Gov /). Oligonucleotide primers for sequencing and PCR are obtained commercially from Kebo Lab (Espoo, Finland). PCR is carried out using Dynazyme polymerase (Finnzymes, Espoo, Finland) under the conditions recommended by the manufacturer, and suitable reaction variables are selected from the variable amplification parameters, taking into account the characteristics of the PCR primers. The primers used to amplify the VAP-1 cDNA fragment from smooth muscle mRNA by RT-PCR are N2; gctgtgatcacmatyttygc (SEQ ID NO: 3) constructed from the N-terminal AVITIFA of the VAP-1 protein sequence (SEQ ID NO: 4) (residues 13 to 19 in the complete protein) and T4; ccggccctgrtagaasac (SEQ ID NO: 5) constructed from the trypsin-treated peptide sequence VFYQGR (SEQ ID NO: 6) (residues 264 to 269). For amplification with the indicated primers, the following conditions are used: 94 <sup class="style-scope patent-text"> C.</sup> , 1 minute; 55 <sup class="style-scope patent-text">o</sup> C, 1 minute; 72 <sup class="style-scope patent-text">o</sup> C, 2 minutes for 30 cycles. Total RNA is obtained from cell lines and tissues using an Ultraspec device (Biotecx, Houston, TX, USA), in accordance with the manufacturer's recommendations. Multiple northern blots from human tissues were obtained from Clontech Laboratories (Palo Alto, CA, USA) and hybridized with <sup class="style-scope patent-text">32</sup> P-labeled samples according to the manufacturer's recommendations. A human cDNA library kit as well as a cDNA library from the lung (catalog No. HL3004a) and heart (catalog No. HL3026a) were obtained from Clontech Laboratories.</span>
  </p>
  <p num="90" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">      VAP-1   . COS-7 ( ),  (   )  CRL1998 (      ),    (Rockville, MD)          VAP-1. COS-7  CRL 1998     RPMI 1640 (Gibco BRL),  10%    (PAA-Linz, ), 2   (Biological Industries, )  128 /   128 / .      -        .  ,    VAP-1,     pcDNA3 (Invitrogen, San Diego, CA)      COS-7         .   (20 )         BIO-Rad Gene Pulser (0,3 kV, 960 ,  0,4    RPMI,   1  Na-, 2  L-,  ).      3    .         0,5 /  (Geneticin, Gibco BRL)   4 .</span>&nbsp;Cell culture and expression of VAP-1 cDNA in mammalian cells. COS-7 (monkey fibroblasts), CHO (Chinese hamster ovary cells), and CRL1998 (immortal human umbilical vein endothelial cells) obtained from ATCC (Rockville, MD) are used as host organisms for transfection and expression of VAP-1. COS-7 and CRL 1998 cells were grown in RPMI 1640 medium (Gibco BRL) containing 10% fetal calf serum (PAA-Linz, Austria), 2 mM glutamine (Biological Industries, Israel) and 128 U / ml penicillin and 128 g / ml streptomycin. CHO cells are grown in alpha-MEM plus CHO with nucleosides and the same additives. Expression plasmids consisting of VAP-1 cDNA are subcloned into pcDNA3 expression vector (Invitrogen, San Diego, CA) and used for transient transfection of COS-7 cells to generate stably transfected CHO cell lines. Expression plasmids (20 g) are used for transfection of cells by electroporation on a BIO-Rad Gene Pulser instrument (0.3 kV, 960 F, 0.4 cm cuvette in RPMI medium containing an additional 1 mM Na-pyruvate, 2 mM L-glutamine , without serum). Temporarily transfected cells are examined 3 days after transfection. Stably transfected cells were selected during cultivation in the presence of 0.5 mg / ml geneticin (Geneticin, Gibco BRL) for 4 weeks.</span>
  </p>
  <p num="91" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  2<br class="style-scope patent-text">   VAP-1<br class="style-scope patent-text">   ,  VAP-1       ,        (),        VAP-1.       ,           .  ,    -  ()  (McInture W. S. and Hartmann ., in Principles and Applications of Quinoproteins, p. 97 (V.L. Davidson. ed., Dekker, New York (1993)).</span>Example 2 <br class="style-scope patent-text"> Enzymatic activity of VAP-1 <br class="style-scope patent-text"> The establishment of the fact that VAP-1 has a pronounced identity with the family of copper-containing aminoxidases, in particular with secreted bovine serum aminoxidase (BSAO), made it logical to study the presence of aminoxidase activity in VAP-1. Copper-containing aminoxidases are characterized by the presence of an unusual quinone cofactor, enzyme binding to copper, and activity against primary polyamines or monoamines. Thus, they differ from FAD-containing intracellular (mitochondrial) monoamine oxidases (McInture WS and Hartmann C., in Principles and Applications of Quinoproteins, p. 97 (VL Davidson. Ed., Dekker, New York (1993)).</span>
  </p>
  <p num="92" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">   ,     VAP-1,      ,  VAP-1 .         ()             ()      .           ,         ,  .   ,  ,  VAP-1,       ,            ( 1).           ()      ,  VAP-1,    ,          ( 1).       .   100    10         (Lyies, Intl. J. Biochem. Cell Biol., 28:254-274 (1996)) VAP-1      ( 1).</span>&nbsp;To determine what type of activity VAP-1 has, the authors obtain stable transfectants of CHO cells expressing the VAP-1 protein. The voiced lysates of these cells are examined for the presence of diamine oxidase (DAO) activity using putrescine as a substrate or for the presence of monoamine oxidase activity (MAO) using benzylamine as a substrate. Commercially available DAO and MAO preparations are used as positive controls, and CHO cell lysates transfected with a pseudoplasmid are used as negative controls. The results show that cells expressing VAP-1 have negligible activity against putrescine, however, when using benzylamine as a substrate for MAO, significant activity was found (Table 1). Moreover, in the case of using benzylamine as a substrate of monoamine oxidase (MAO), significant activity is observed in CHO cells expressing VAP-1, and in the positive control, which is a commercially available MAO preparation from bovine plasma (Table 1). Pseudolysates of CHO cells exhibit slight enzymatic activity. In the presence of 100 M semicarbazide and 10 M hydroxylamine as specific inhibitors of copper-containing monoamine oxidases (Lyies, Intl. J. Biochem. Cell Biol., 28: 254-274 (1996)), VAP-1 is not active with benzylamine (Table 1).</span>
  </p>
  <p num="93" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  ,   ,     VAP-1,    ,       ,      ( 1).   ,         ,      ,   ""      ( 1).</span>&nbsp;In addition, the authors showed that the adhesion competent VAP-1 expressed in Ax cells also has MAO activity against benzylamine, which is inhibited by semicarbazide and hydroxylamine (Table 1). Apparently, the Ah cells themselves have native MAO activity with benzylamine, which is not inhibited by semicarbazide or hydroxylamine, since a low level of activity is noted in the "pseudo-control" cells (Table 1).</span>
  </p>
  <p num="94" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">   ,      VAP-1 in vivo,    VAP-1            . VAP-1  ,   VAP-1    ,        <sub class="style-scope patent-text">490</sub>  0,09  37<sup class="style-scope patent-text">o</sup>    ,   4,5        .            VAP-1      .</span>To confirm that MAO activity is present in VAP-1 in vivo, the authors carried out the purification of VAP-1 from tonsils by the immunoaffinity method and analyzed the obtained material in triplicate. VAP-1 from tonsils, like VAP-1 from transfected CHO cells, shows activity with benzylamine with an hourly increase of A <sub class="style-scope patent-text">490</sub> by 0.09 at 37 <sup class="style-scope patent-text">o</sup> C under the existing test conditions, which is 4.5 times higher than the specified parameter in the case of boiled sample. However, due to the very low yield of VAP-1 protein obtained from tonsils, it was not possible to determine the specific activity of the drug.</span>
  </p>
  <p num="95" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ,          ,   in vivo. ,               VAP-1 ( 1).   ,    1     VAP-1, ,           .          ,       ,    1,      VAP-1,     .</span>&nbsp;Benzylamine, which is usually used as a substrate for determining aminoxidase activity, was not detected in vivo. Thus, many bioavailable endogenous amines have been tested in terms of establishing their ability to utilize VAP-1 (Table 1). Apparently, methylamine at a concentration of 1 mM can easily be utilized by VAP-1, however, none of the other amines studied shows such reactivity. In these cell lysates, a lower specific activity with benzylamine is observed when compared with the data on lysates shown in Table 1, which reflects the variations in VAP-1 expression available in different cell series.</span>
  </p>
  <p num="96" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">     VAP-1     -     -  VAP-1        .     -/ Na  -          (Paz . A. et al., J. Biol. Chem., 266: 689-692 (1991)).       VAP-1  90 ,       180 ,    ,  VAP-1   ,   ,     .</span>&nbsp;The presence of the quinone factor in VAP-1 was shown during separation in SDS-PAGE under reducing conditions of a part of the immunopurified material VAP-1 from tonsils with subsequent transfer of the material to nitrocellulose. The nitrocellulose filter is then stained with nitrobluetetrazolium / Na glycinate under redox conditions to specifically stain the quinone groups of the protein (Paz M. A. et al., J. Biol. Chem., 266: 689-692 (1991)). The dye reacts with both a VAP-1 monomeric region of 90 kDa and a 180 kDa dimeric region, which indicates that tonsil VAP-1 appears to have a quinone cofactor in each subunit.</span>
  </p>
  <p num="97" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">   <br class="style-scope patent-text">   .      (10-1510<sup class="style-scope patent-text">6</sup>  ),      VAP-1,     10  100   ,  7,2,      10  .      1,5            2   10    (  Braun sonicator).        (50-100   )     -20<sup class="style-scope patent-text">o</sup>.              -   Bio-Rad Protein Assay (Bio-Rad Laboratories, Hercules, CA, ).</span>Materials and methods <br class="style-scope patent-text"> Determination of aminoxidase activity. Merging CHO or Ax cells (10-15 x 10 <sup class="style-scope patent-text">6</sup> per flask) stably transfected with plasmid cDNA of VAP-1 expression are scraped from the flask in 10 ml of 100 mM phosphate buffer, pH 7.2, centrifuged and the cell pellet washed with 10 ml of buffer. The cell pellet is finally resuspended in 1.5 ml of phosphate buffer and the cells are lysed by sounding with <figure-callout id="2" label="medium power pulses" filenames="00000008.png,00000009.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">medium power pulses</a></figure-callout> 2 times for 10 seconds on ice (Braun sonicator ultrasonic device). Pronounced lysates are used directly in enzymatic tests (50-100 l per test) or after storage at -20 <sup class="style-scope patent-text">o</sup> C. The total protein concentration is measured by the Bradford method using bovine gamma globulin and Bio-Rad Protein Assay kit (Bio- Rad Laboratories, Hercules, CA, USA).</span>
  </p>
  <p num="98" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">               <sup class="style-scope patent-text">14</sup>-  (Amersham),   '  . (D'Agostino L. et al., Biochem. Pharmacol. , 38: 47-49 (1989),      ), <sup class="style-scope patent-text">3</sup>H  (New England Nuclear)      (Baylin S.B. and Margolis S. , Biochem. Biophys. Acta, 397:294-396 (1975),      ),  <sup class="style-scope patent-text">14</sup>-  (Amersham)       ,   ,           0,4 Ci,   80   . 0,5     100  - ,  7,2, 0,4 i <sup class="style-scope patent-text">14</sup>- (Amersham), 80            100     .    37<sup class="style-scope patent-text">o</sup>   1       900  ,  0,35 / ,    .     700            700  /,  500   ,         <sup class="style-scope patent-text">14</sup>    - .        ,    (10 , 100<sup class="style-scope patent-text">o</sup>)   ,               <sup class="style-scope patent-text">-1</sup>  <sup class="style-scope patent-text">-1</sup>.               Sigma Chemical Company (St. Louis, , ).</span>Aminoxidase activity is measured in accordance with the previously described methods when using <sup class="style-scope patent-text">14</sup> C-labeled putrescine (Amersham) as substrates, according to the method of D'Agostino et al. (D'Agostino L. et al., Biochem. Pharmacol., 38: 47-49 (1989), incorporated by reference), <sup class="style-scope patent-text">3</sup> H histamine (New England Nuclear) according to the method of Baylin SB and Margolis (Baylin SB and Margolis S., Biochem. Biophys. Acta, 397: 294-396 (1975), incorporated herein by reference), and <sup class="style-scope patent-text">14</sup> C-benzylamine (Amersham) and are determined analogously to the method with putrescine, except that as a substrate the reaction uses a label with a radioactivity of 0.4 Ci, which contains 80 nmol of unlabeled benzylamine. 0.5 ml of the reaction mixture contains 100 mM sodium phosphate buffer, pH 7.2, 0.4 Ci <sup class="style-scope patent-text">14</sup> C-benzylamine (Amersham), 80 nmol of the intended benzylamine and a sample of crude cell lysate with a maximum volume of 100 l per reaction. After incubation at 37 <sup class="style-scope patent-text"> C.</sup> for 1 hour, the aldehyde reaction product was extracted by adding 900 l of toluene containing 0.35 g / l of diphenyloxazole and the mixture was shaken vigorously. After phase separation, 700 l of the toluene layer was taken and further extraction was carried out using 700 l of toluene / diphenyloxazole, 500 l of the specified layer was taken, added to the first extracted portion and the level of <sup class="style-scope patent-text">14</sup> C was counted in a liquid scintillation counter. All enzymatic tests are performed in the presence of blind controls containing a boiled sample (10 minutes, 100 <sup class="style-scope patent-text"> C.</sup> ) or a non-expressing sample, in duplicate or triplicate, and the results are expressed as pmol of substrate used min <sup class="style-scope patent-text">-1</sup> mg protein <sup class="style-scope patent-text">-1</sup> . Controls of crude DAO from pig kidney and MAO from bovine plasma were obtained from Sigma Chemical Company (St. Louis, MO, USA).</span>
  </p>
  <p num="99" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <br class="style-scope patent-text">     MAT 1B2,  VAP-1,        ,      PLN . ,    VAP-1,    ,  ,         VAP-1,         .    ,     VAP-1,              ,    (Salmi M. et al. , J. Exp. Med., 178:2255-2260 (1993)). VAP-1        , , ,     ,       ,       PLN .</span>Discussion <br class="style-scope patent-text"> Marked staining using MAT 1B2 recognizing VAP-1 is indicated in vascular endothelial cells in several positions, especially in PLN type lymphoid tissues. However, since the overall level of VAP-1 found in these areas is relatively low, it was difficult to isolate and purify sufficient amounts of endothelial VAP-1 in order to obtain the desired protein sequence information. If we consider other tissues in which VAP-1 was found, then it is most abundantly present in the smooth muscles of the vascular system and in the smooth muscles belonging to the intestine (Salmi M. et al., J. Exp. Med., 178: 2255- 2260 (1993)). VAP-1 from these sources is characterized by slightly different molecular weights, which is probably due to differences in glycosylation, and is nevertheless close to the form obtained previously from tonsils and PLN type tissues.</span>
  </p>
  <p num="100" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">      ,   VAP-1,       ,  ,    .    : -,    VAP-1            VAP-1.  -,  ,   YAP-1,     MAT 1B2,       VAP-1 (Salmi M. and Jalkanen S. , Science, 257:1407-1409 (1992))  VAP-1,     ,     in vivo    (170-180 ).</span>&nbsp;Using protein sequence data obtained for VAP-1 isolated and purified from the smooth muscle of the intestine, cDNA encoding the specified adhesion molecule was isolated. Proof of this is as follows: firstly, the protein sequence obtained for immunopurified VAP-1 was found in the predicted protein sequence of the subsequently isolated VAP-1 cDNA clone. And secondly, transfected cells expressing YAP-1 cDNA are stained superficially using MAT 1B2, which was originally used to determine VAP-1 (Salmi M. and Jalkanen S., Science, 257: 1407-1409 (1992)) and VAP-1, isolated by immunoprecipitation from these cells, has a molecular weight close to the in vivo protein (170-180 kDa).</span>
  </p>
  <p num="101" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> VAP-1        II,   ,   N- .         4   ,             163 .    ,    ,   12 N-   6 O-,    .     ,    ,     ,  VAP-1   N-,  O- ,      ,        N- ,    O- .  ,    ,  ,        VAP-1  (Salmi . and Jalkanen S., J. Exp. Med., 183: 569-579 (1996)),   ,          .</span>&nbsp;VAP-1 is a large dimeric type II transmembrane protein having a membrane domain located at the N-terminus of the molecule. The intracellular domain is especially small and contains only 4 amino acids in length, while the large glycosylated extracellular domain has a size of about 163 kDa in the indicated dimer. All potential glycosylation sites per dimer, namely 12 N-linked and presumably 6 O-linked, are located in the extracellular domain. Although it is not currently known whether all of them are used, previously obtained data suggest that VAP-1 contains both N- and O-linked sugars, as well as many sialic acid residues that may be present either on terminal N-linked carbohydrate residues , or as part of O-linked sugar. Since carbohydrates, in particular sialic acids, are believed to play an important role in the realization of the adhesive function of the VAP-1 protein (Salmi M. and Jalkanen S., J. Exp. Med., 183: 569-579 (1996)), it seems necessary determine which glycosylation sites are used and what kind of carbohydrates they contain.</span>
  </p>
  <p num="102" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">    -     -     VAP-1    ,     VAP-1, a       ,    ,    VAP-1,    .  ,  ,    ,    VAP-1,         . ,       ,     ,    ,    ,      VAP-1      , ,       ,       .  ,  ,  ()  () () VAP-1, () ,      .</span>&nbsp;Since analysis by Northern blotting did not reveal the presence of VAP-1 mRNA species with significantly different sizes in any tissue, and all VAP-1 cDNA clones, as well as the PCR fragments studied, contain similar sequences, there is no good reason to believe that there are forms VAP-1 encoded by different variants of mRNA. Thus, it is possible that the inventors clone cDNA encoding the predominant form of VAP-1, which was previously investigated by immunoblotting and immunoprecipitation. However, since all studied tissues contain smooth muscles originating either from vascular tissues or from other sources, as well as vascular endothelium, it is impossible to distinguish between VAP-1 mRNA from smooth muscles and endothelium when, as is the case in these tissues , they contain very close types of mRNA. Thus, it is possible that there may be other form (s) of VAP-1 encoded by the mRNA slightly different from the already isolated species.</span>
  </p>
  <p num="103" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  ,  N-  VAP-1       ,       . ,      ,      ,        N-,         (Mu D. et al., J. Biol. Chem., 269:9926-9932 (1994)).  ,   VAP-1      .    ,   VAP-1   ,   ,      VAP-1 ,  ,      ,    .   VAP-1   ,   VAP-1    .            ,          :  ,      ,     ,  ,   VAP-1,    .    ,        .</span>&nbsp;It seems interesting that the N-terminal region of VAP-1 with the transmembrane region is the part of the molecule that is most different from that in homologous BSAO. BSAO is known to be a secreted protein found in high amounts in serum that carries a secretion signal sequence at its N-terminus that is removed during proteolytic processing during secretory metabolism (Mu D. et al., J. Biol. Chem., 269: 9926-9932 (1994)). Thus, BSAO and VAP-1 may not have similar physiological properties. Preliminary data suggest that murine VAP-1 has a transmembrane domain similar to that found in human VAP-1 and, thus, may have the same functions as the human molecule. The extracellular domain of VAP-1 has aminoxidase activity, so that VAP-1 can function as an ectoenzyme. Copper-containing aminoxidases are a heterogeneous class of enzymes with very different substrate specificities, which can be roughly roughly divided into two large types: those that have activity against polyamines, such as putrescine and histamine, and those such as VAP-1, which have monoamine oxidase activity. The physiological substrates of aminoxidases are unknown, although there is speculation about several of these possible compounds.</span>
  </p>
  <p num="104" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">          ,        ,            (6- ),       .    ,  ,       ,      .       ,      (Lyies G. A., Intl. J. Biochem. Cell Biol., 28:259-274 (1996)),         ().  ,  VAP-1  - , ,        , , ,    ,     .  ,      VAP-1    -   , -   ,  VAP-1      .</span>&nbsp;Another characteristic feature of these enzymes is the presence of an unusual carbonyl-containing cofactor, on the chemical nature of which conflicting data were obtained, which was identified in BSAO and in pea aminoxidase as topachinone (6-hydroxydopa), and in lysyl oxidase as cross-linked lysintyrosylquinone. In some mammalian species, including humans, copper-containing monoamine oxidase is found in both the cell membrane and serum in soluble form. This activity is sensitive to inhibition by carbonyl reactive agents, such as semicarbazide and hydroxylamine (Lyies G. A., Intl. J. Biochem. Cell Biol., 28: 259-274 (1996)), and such enzymes are classified as semicarbazide-sensitive aminoxidases (CCAO). The authors showed that VAP-1 contains covalently bound quinone, which, taking into account the available data on other copper-containing monoamine oxidases, is probably formed by self-processing in a reaction involving an enzyme connected with copper. These results, as well as the sensitivity of the enzymatic activity of VAP-1 to carbonyl reactive agents  semicarbazide and hydroxylamine  indicate that VAP-1 is an SCAO associated with the membrane.</span>
  </p>
  <p num="105" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">     ,        in vivo,           .            ,  ,        VAP-1,   ,    ,    .</span>&nbsp;The physiological role of SCAR is difficult to determine, since very little is known about their substrates in vivo, and their substrate specificity varies significantly among different species. One of these functions may be the metabolism of endogenous and xenobiotic primary monoamines, and it is possible that the VAP-1 function found in positions other than endothelial tissues, such as smooth muscles, belongs to this genus.</span>
  </p>
  <p num="106" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">    ,     VAP-1 -      .     in vitro,   CRL1998   PBL  (  ),  VAP-1     ,  ,             ,       PBL,    VAP-1 , . , ,     ,          ,  ,    ,            , ,  ,   .</span>&nbsp;It is currently unknown whether VAR-1 activity has any role in realizing the adhesive properties of cells. Preliminary in vitro adhesion experiments carried out with CRL1998 cells and PBL cells (peripheral blood lymphocytes) transfected with VAP-1 in the presence of semicarbazide and hydroxylamine suggest that enzymatic activity may have a negative effect on adhesive interactions between these cells, since in the presence of of said inhibitors, the amount of PBL associated with transfected VAP-1 cells is increasing. However, it is not known whether this effect is primary, caused by the direct and specific action of enzymatic activity on the adhesive mechanism used by cells, or whether it is secondary, in which the physiological state of cells is adversely affected by the product of monoamine oxidase activity, thus reducing their adhesive potential .</span>
  </p>
  <p num="107" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  3<br class="style-scope patent-text">   <br class="style-scope patent-text">  VAP-1  pcDNA3         ,   HEV<br class="style-scope patent-text"> , ,  ,        VAP-1,    -,   .   ,     VAP-1,          (.6 ),         .      PBL   VAP-1     25,6  ,     (. 6  6).    VAP-1    ,     ,      VAP-1 (  29,6%  10,7%, =0,05).         ,    2-3   ,           PBL    .   ,   VAP-1    ,         ,     ,       PBL.</span>Example 3 <br class="style-scope patent-text"> Adhesion test <br class="style-scope patent-text"> VAP-1 cDNA in pcDNA3 is used to transfect Ax cells and the endothelial cell line derived from HEV <br class="style-scope patent-text"> rats, which are believed to be able to create a more natural functional environment for VAP-1 than other potential host cells, such as CHO. Stable transfectants are obtained that express VAP-1 on the cell surface, which was determined by sorting the cells by fluorescence intensity (FIG. 6 A), which are then used in lymphocyte adhesion tests. When tested under rotation conditions, PBL binds to VAP-1 transfected Ax cells 25.6 times better than to pseudotransfected cells (Figs. 6B and 6C). Increased binding to VAP-1 transfectants is statistically significantly inhibited, although not completely eliminated, when treated with a monoclonal antibody against VAP-1 (inhibition by 29.6%  10.7%, P = 0.05). The indicated adhesion results are combined from five independent experiments in which 2-3 parallel monolayers of transfectants are analyzed, each time using three independently transfected cell lines and PBL from six different donors. The data obtained show that VAP-1 cDNA encodes a functional adhesion molecule that is located on the cell surface of transfected cells and which, when expressed in Ax cells, can be a direct mediator of binding to PBL.</span>
  </p>
  <p num="108" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">   <br class="style-scope patent-text"> -,   VAP-1  ,  ""            (20000     2 ).                      100   RPMI 1640,  10%     10  HEPES (  ).            PBL       4010<sup class="style-scope patent-text">6</sup> /   .       ,    60     7<sup class="style-scope patent-text">o</sup>,       5   PBL.     30    .            RPMI    .                   ,  1% .         (  200).     0,25 <sup class="style-scope patent-text">2</sup>.         0,25 <sup class="style-scope patent-text">2</sup>   ,     .             (   4,5 <sup class="style-scope patent-text">2</sup>).          MAT,   VAP-1 ( 12  -14,     50 /     )    - MAT ( 3G6  77,     50 /). MAT         30   7<sup class="style-scope patent-text">o</sup>    .         ,    .</span>Materials and methods <br class="style-scope patent-text"> Ax cells in which VAP-1 is stably expressed, or pseudo-control transfectants are placed on wax-circled circles on gelatin-coated microscopic plates (20,000 cells per 2 cm diameter circle). Cells are grown before fusion, and after two washes, 100 l of RPMI 1640 medium containing 10% fetal calf serum and 10 mM HEPES (test medium) are added to each wax circle outlined under uniform coating of the sticky cell monolayer. Meanwhile, PBL is isolated from freshly obtained blood by centrifugation in ficoll and their concentration is adjusted to 40 x 10 <sup class="style-scope patent-text">6</sup> cells / ml with test medium. After that, the plates are transferred to an angular shaker operating at a speed of 60 rpm at 7 <sup class="style-scope patent-text"></sup> C, and 5 l of PBL suspension is applied to each wax circle. The test is continued for 30 minutes with constant rotation. The plates are carefully decanted and immersed once in cold RPMI medium to remove non-adherent cells. Adherent cells are fixed on the slices during incubation of the plates overnight in an upright position in ice-cooled PBS containing 1% glutaraldehyde. Count the number of adherent cells using an ocular network (magnification x 200). The net covers an area of 0.25 mm <sup class="style-scope patent-text">2</sup> . On each glass, nine predetermined areas of 0.25 mm <sup class="style-scope patent-text">2</sup> in the center of the circle are counted, where the transfectants formed a fused monolayer. In each of the five independent experiments, two plates per sample are counted (total area is 4.5 mm <sup class="style-scope patent-text">2</sup> ). In some experiments, the adhesion test is carried out in the presence of MAT blocking the function of VAP-1 (combination of 1B2 and TK-14, both are used at a concentration of 50 g / ml with dilution with test medium) or negative control class-specific MAT (combination of 3G6 and 7C7 , both apply at a concentration of 50 mct / ml). MATs are incubated with a monolayer of transfectants on plates for 30 minutes at 7 <sup class="style-scope patent-text"> C.</sup> until labeled lymphocytes are added. The number of adherent cells is counted in five independent experiments, as described above.</span>
  </p>
  <p num="109" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <br class="style-scope patent-text">   ,    ,  VAP-1, ,     VAP-1,         PBL      PBL   .          MAT  VAP-1 (1B2  8-14),   ,   VAP-1        ,    . ,      ,      VAP-1         HEV,   MAT       VAP-1   .  ,    VAP-1      ,      ,  MAT 1B2  8-14.  ,     ,    VAP-1      () ()     .     , ,    MAT  VAP-1.     HEV ,  VAP-1     L-    CD8<sup class="style-scope patent-text">+</sup>PBL  ,  CD4<sup class="style-scope patent-text">+</sup>PBL.  ,    VAP-1,   ,       L- ,   CD8<sup class="style-scope patent-text">+</sup>  CD4<sup class="style-scope patent-text">+</sup> , ,  L-            CD8<sup class="style-scope patent-text">+</sup>   PBL        VAP-1 ,  CD4<sup class="style-scope patent-text">+</sup>  (  ).</span>Discussion <br class="style-scope patent-text"> Adhesion tests performed with Ax cells expressing VAP-1 show that cDNA encodes a functional VAP-1 that can support interaction with its ligand on PBL and leads to stable binding of PBL to Ax cells. However, there is no complete inhibition of such increased adhesion with MAT against VAP-1 (1B2 and TK8-14), which suggests that the VAP-1 molecule in rat Ax cells does not function exactly as it does in the native environment. It is possible that the modification of carbohydrates in the proteins of Ax cells, the local membrane environment, or the conformation of VAP-1 differ sufficiently from those in human HEV, so that MAT can no longer block all interactions of VAP-1 with its ligand. It is also possible that a subpopulation of VAP-1 molecules can exist in transfectants in a form lacking one or the other of the epitopes recognized by MAT 1B2 and TK8-14. Finally, the authors focused on the possibility that prolonged superexpression of VAP-1 in stable transfectants alters the expression of other adhesion molecules (s) on the surface of Ax cells. The function of other putative adhesion molecules, of course, will not be inhibited by MAT against VAP-1. HEV binding tests have shown that VAP-1 functions independently of lymphocytic L-selectin and mediates CD8 <sup class="style-scope patent-text">+</sup> PBL binding much better than CD4 <sup class="style-scope patent-text">+</sup> PBL. Ax cells obtained by transfection of VAP-1 cDNA reproduce these properties, since analysis of immunomagnetically purified L-selectin negative cells, as well as CD8 <sup class="style-scope patent-text">+</sup> and CD4 <sup class="style-scope patent-text">+</sup> cells, showed that L-selectin is not necessary for effective binding to Ax transfectants and that a subset of CD8 <sup class="style-scope patent-text">+</sup> cells in PBL is characterized by several times better adherence to VAP-1 transfectants than CD4 <sup class="style-scope patent-text">+</sup> cells (data not shown).</span>
  </p>
  <p num="110" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">   ,        , ,        ,              ,         ,        ,                       .</span>&nbsp;Despite the fact that the invention is described with respect to specific variants of its implementation, it is obvious that it can be subjected to other modifications, and the present application generally covers all possible options for the use or adaptation of the description, principles of the invention and includes such deviations from the present disclosure that are already known or usually practiced in the technique to which the present invention relates and which may be applicable to the essential features in the specified description and which cover the scope of the claims.</span>
  </p>
  <p num="111" class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">   ,      ,   ,        .</span>&nbsp;The disclosure of all references, patent applications, and citation of patents, if any, are hereby incorporated by reference in their entirety.</span>
  </p>
</description>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(2)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result">translated from Russian</div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><claims mxw-id="PCLM75679857" lang="EN" load-source="google" class="style-scope patent-text">
  <claim num="1" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 1.        ,   -1  (VAP-1),   ,   ,   . 1 (SEQ ID NO: 2),  ,         -  .</span>&nbsp;1. A method of manipulating the process of binding of endothelial cells to lymphocytes, mediated by vascular adhesion protein-1 (VAP-1) having amino oxidase activity, having the amino acid sequence shown in FIG. 1 (SEQ ID NO: 2), characterized in that the inhibition of the enzymatic activity of amino oxidase is carried out by introducing an amino oxidase inhibitor into the host cell.</span>
    </claim-text>
  </claim>
  <claim num="2" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 2.        ,   -1  (VAP-1),   ,   ,   . 1 (SEQ ID NO: 2),  ,         -  .</span>&nbsp;2. A method of manipulating the process of binding of endothelial cells to lymphocytes, mediated by vascular adhesion protein-1 (VAP-1), having amino oxidase activity, having the amino acid sequence shown in FIG. 1 (SEQ ID NO: 2), characterized in that the potentiation of the enzymatic activity of the amino oxidase is carried out by introducing an amino oxidase potentiator into the host cell.</span>
    </claim-text>
  </claim>
</claims>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (2)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US39447A/en"><a id="link" href="#" class="style-scope state-modifier">US39447A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">1863-08-04</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Improvement in truss-bridges </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU671837B2/en"><a id="link" href="#" class="style-scope state-modifier">AU671837B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-06-09</span>
                    <span class="td style-scope patent-result">1996-09-12</span>
                    <span class="td style-scope patent-result">Oy Biotie Therapies Ltd</span>
                    <span class="td style-scope patent-result">A novel endothelial cell molecule mediating lymphocyte binding in man 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner,  Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="nplCitations" class="scroll-target style-scope patent-result">
              Non-Patent Citations (1)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      SALMI M. et al., A 90-Kildalton endothelial cell Molecule mediating lymphocyte binding in humans, Science, 1992, v.257, Sept., .1407-1409.
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner,  Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (8)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/RU2459832C2/en"><a id="link" href="#" class="style-scope state-modifier">RU2459832C2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-04-20</span>
                    <span class="td style-scope patent-result">2012-08-27</span>
                    <span class="td style-scope patent-result">  </span>
                    <span class="td style-scope patent-result">New completely human vap-1 monoclonal antibodies 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7285416B2/en"><a id="link" href="#" class="style-scope state-modifier">US7285416B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-01-24</span>
                    <span class="td style-scope patent-result">2007-10-23</span>
                    <span class="td style-scope patent-result">Gendaq Limited</span>
                    <span class="td style-scope patent-result">Regulated gene expression in plants 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2433408A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2433408A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-02-23</span>
                    <span class="td style-scope patent-result">2002-08-29</span>
                    <span class="td style-scope patent-result">Biovitrum Ab</span>
                    <span class="td style-scope patent-result">Method for purification of soluble ssao 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/FI20020807A0/en"><a id="link" href="#" class="style-scope state-modifier">FI20020807A0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-04-29</span>
                    <span class="td style-scope patent-result">2002-04-29</span>
                    <span class="td style-scope patent-result">Biotie Therapies Oyj</span>
                    <span class="td style-scope patent-result">
  Novel humanized anti-VAP-1 monoclonal antibodies
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004104191A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2004104191A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-05-26</span>
                    <span class="td style-scope patent-result">2004-12-02</span>
                    <span class="td style-scope patent-result">Biotie Therapies Corporation</span>
                    <span class="td style-scope patent-result">Crystalline vap-1 and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/FI20050640A0/en"><a id="link" href="#" class="style-scope state-modifier">FI20050640A0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-06-16</span>
                    <span class="td style-scope patent-result">2005-06-16</span>
                    <span class="td style-scope patent-result">Faron Pharmaceuticals Oy</span>
                    <span class="td style-scope patent-result">
  Compounds for treating or preventing diseases or disorders related to amine oxidases
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2010515461A/en"><a id="link" href="#" class="style-scope state-modifier">JP2010515461A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-01-10</span>
                    <span class="td style-scope patent-result">2010-05-13</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">
  A method for measuring the stability of organic methyleneamines in the presence of semicarbazide-sensitive amine oxidase
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/UA112154C2/en"><a id="link" href="#" class="style-scope state-modifier">UA112154C2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-09-08</span>
                    <span class="td style-scope patent-result">2016-08-10</span>
                    <span class="td style-scope patent-result">  .</span>
                    <span class="td style-scope patent-result">Use of vap-1 inhibitors for treating fibrotic conditions 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner,  Cited by third party,  Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/12814740918028481023"><a id="link" href="#" class="style-scope state-modifier">Hoops et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991</span>
                    <span class="td style-scope patent-result">Isolation of the cDNA encoding glycoprotein-2 (GP-2), the major zymogen granule membrane protein: homology to uromodulin/Tamm-Horsfall protein</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU707349B2/en"><a id="link" href="#" class="style-scope state-modifier">AU707349B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-07-08</span>
                    <span class="td style-scope patent-result">Cloning and regulation of an endothelial cell protein C/activated protein C receptor 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0814158A2/en"><a id="link" href="#" class="style-scope state-modifier">EP0814158A2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-12-29</span>
                    <span class="td style-scope patent-result">Human C3a receptor variant; uses in diagnostics and therapeutics 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2002516103A/en"><a id="link" href="#" class="style-scope state-modifier">JP2002516103A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-04</span>
                    <span class="td style-scope patent-result">
  Interleukin 21 and interleukin 22
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU8767698A/en"><a id="link" href="#" class="style-scope state-modifier">AU8767698A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-03-01</span>
                    <span class="td style-scope patent-result">Novel orphan receptor 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/RU2204838C2/en"><a id="link" href="#" class="style-scope state-modifier">RU2204838C2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-05-20</span>
                    <span class="td style-scope patent-result">Vascular adhesion protein-1 of aminooxidase activity 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH11225774A/en"><a id="link" href="#" class="style-scope state-modifier">JPH11225774A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-08-24</span>
                    <span class="td style-scope patent-result">Member of immunoglobulin gene superfamily, pigr-1 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2252432A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2252432A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-11-06</span>
                    <span class="td style-scope patent-result">Mammalian mixed lymphocyte receptors, chemokine receptors [mmlr-ccr] 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1999046377A2/en"><a id="link" href="#" class="style-scope state-modifier">WO1999046377A2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-09-16</span>
                    <span class="td style-scope patent-result">A human vanilloid receptor-like cation channel 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH10504714A/en"><a id="link" href="#" class="style-scope state-modifier">JPH10504714A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-05-12</span>
                    <span class="td style-scope patent-result">
  Human potassium channel 1 and 2 proteins
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6664383B1/en"><a id="link" href="#" class="style-scope state-modifier">US6664383B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-12-16</span>
                    <span class="td style-scope patent-result">Polypeptides, cDNA encoding the same and utilization thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2003210183A/en"><a id="link" href="#" class="style-scope state-modifier">JP2003210183A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-07-29</span>
                    <span class="td style-scope patent-result">HUMAN IkappaB-beta 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030022312A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030022312A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-30</span>
                    <span class="td style-scope patent-result">Human hepatoma-derived growth factor-2 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6037163A/en"><a id="link" href="#" class="style-scope state-modifier">US6037163A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-03-14</span>
                    <span class="td style-scope patent-result">Human microfibril-associated glycoprotein 4 splice variant 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6130061A/en"><a id="link" href="#" class="style-scope state-modifier">US6130061A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-10-10</span>
                    <span class="td style-scope patent-result">Human stem cell antigen 2 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH11215989A/en"><a id="link" href="#" class="style-scope state-modifier">JPH11215989A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-08-10</span>
                    <span class="td style-scope patent-result">Member of immunoglobulin gene super family, pigr-2 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1999051634A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1999051634A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-10-14</span>
                    <span class="td style-scope patent-result">Human gap junction protein beta-3 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6844323B2/en"><a id="link" href="#" class="style-scope state-modifier">US6844323B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-01-18</span>
                    <span class="td style-scope patent-result">Polypeptide-calcitonin 11 and the polynucleotide encoding it 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20020055476A1/en"><a id="link" href="#" class="style-scope state-modifier">US20020055476A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-05-09</span>
                    <span class="td style-scope patent-result">RAMP2a: receptor activity modifying protein-2a 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1999062947A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1999062947A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-09</span>
                    <span class="td style-scope patent-result">A human ubiquinone oxireductase subunit ci-pdsw homolog gene (cblaic08) 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000009556A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2000009556A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-02-24</span>
                    <span class="td style-scope patent-result">Human lysophospholipase gene (cbfblh05) 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1999036525A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1999036525A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-07-22</span>
                    <span class="td style-scope patent-result">Cbfblh12: a gene highly related to bovine ci-kfyi gene for ubiquinone oxireductase complex 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH11507506A/en"><a id="link" href="#" class="style-scope state-modifier">JPH11507506A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-07-06</span>
                    <span class="td style-scope patent-result">
  Endothelial monocyte active polypeptide III
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1999018990A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1999018990A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-04-22</span>
                    <span class="td style-scope patent-result">The il-1 receptor related protein 3 (il-1rrp3) 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2002095486A/en"><a id="link" href="#" class="style-scope state-modifier">JP2002095486A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-04-02</span>
                    <span class="td style-scope patent-result">Human potassium channel 1 and 2 protein 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (2)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US86243397A<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1997-05-23</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US08/862,433<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1997-05-23</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.4182411283" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.4182411283" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=515968745" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>